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INTRODUCTION 
 
NEURONAL DENDRITES 
The brain contains a vast network of almost 100 billion of neurons that are cells specialized in 
intracellular communication (Purves, 2008). Although the morphology of various types of neurons 
differs in some aspects, they all contain four distinct regions with differing functions: the cell body, 
the dendrites, the axon, and the axon terminals (Lodish, 2000). 
Most neurons have multiple dendrites, which extend out-ward from the cell body and are 
specialized to receive chemical signals from the axon termini of other neurons. Dendrites convert 
these signals into small electric impulses and transmit them inward, in the direction of the cell body. 
Neuronal cell bodies can also form synapses and thus receive signals. Particularly in the central 
nervous system, neurons have extremely long dendrites with complex branches. This allows them to 
form synapses and receive signals from a large number of other neurons (Lodish, 2000). 
Dendrites differ from axons in many important aspects, both morphologically and functionally 
(Craig and Banker, 1994). Dendrites have specialized structures including spines, which are the 
main excitatory synaptic sites that are not found in axons. Unlike axons, dendrites have tapering 
processes such that distal branches have smaller diameters than proximal ones. Furthermore, 
dendrites and axons contain different types of organelles, such as Golgi outposts, found primarily in 
dendrites. The orientation of microtubules also differs considerably in dendrites and axons; in both 
vertebrates and invertebrates, the microtubules uniformly orient with their plus-end distally in 
axons, whereas dendrites contain microtubules of both orientations (Baas et al., 1988; Rolls et al., 
2007). It is likely that these different cytoskeletal arrangements influence the manner in which 
organelles and molecules are transported along axons and dendrites. Given their many structural 
and functional differences, axon and dendrite development must differ in crucial ways (Goldberg, 
2004). Indeed, molecules that function specifically in dendrite or axon growth have been 
discovered. 
Dendritic arbor development is a complex, multi-step process (Fig. a), which generally can be 
divided, into several different, although partially overlapping, stages: (I) neurite initiation, 
outgrowth and guidance; (II) branching and synapse formation, and (III) stabilization (Scott and 
Luo, 2001; Portera-Cailliau et al., 2003; Williams and Truman, 2004).  
Although the time scale of these steps differs between species, the sequence of events seems to be 
very similar. Initial dendrite growth is relatively slow, and a very fast period of dendritic extension 
follows. For example, total dendritic length increased from ~50 to 100 µm during first 24 h of X. 
laevis tectal neurons dendritic arbor development but almost 4-fold increase was observed during 
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the next 48 hours (Wu et al., 1999). Subsequently, dynamic dendritic branching occurs, which 
combined with neuronal activity and synapse formation, leads to the establishment of a well-
developed dendritic arbor. Stabilization of the dendritic arbor occurs over a long period of time (Wu 
et al., 1999; Williams and Truman, 2004). While the development of dendritic tree associates with 
high rates of branch additions and retractions, the mature dendritic arbor is less plastic with a very 
low branch turnover under basal conditions (Wu et al., 1999). Nevertheless, dendritic arbors in the 
mature nervous system preserve some degree of plasticity (Urbanska et al., 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. a. Development of dendritic arbor consists of several overlapping stages (Urbanska et al., 2008). 
 
 
The complex processes of dendritic arbor development and stabilization must be highly 
orchestrated at the molecular level. Recent advances in genetic manipulations of neuronal cells 
helped to reveal a complicated interacting network of dozens, if not hundreds, of proteins involved 
in signal transduction, macromolecule synthesis, cytoskeleton rearrangements and intracellular 
trafficking of proteins and membranes. These processes are regulated by both an intrinsic genetic 
program and a wide variety of extracellular signals, either globally at the whole-cell level or locally 
in dendrites (Urbanska et al., 2008). 
Starting with the seminal work of Ramon y Cayal, the complexity and diversity of dendritic arbors 
has been recognized and well documented. Transcription factors, receptor–ligand interactions, 
various signalling pathways, local translational machinery, cytoskeletal elements, Golgi outposts 
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and endosomes have been identified as contributors to the organization of dendrites of individual 
neurons and the placement of these dendrites in the neuronal circuitry. 
Dendrites must satisfy the following physiological requirements to ensure proper neuronal function. 
First, a neuron’s dendrites need to cover the area (its dendritic field) that encompasses its sensory 
and/or synaptic inputs (Wassle and Boycott, 1991; MacNeil and Masland, 1998). Second, the 
branching pattern and density of dendrites must be suitable for sampling and processing the signals 
that converge onto the dendritic field (Losonczy et al., 2008; Spruston, 2008). Third, dendrites need 
to have the flexibility for adjustment in development and in response to experience (Jan and Jan). 
Many transcription factors contribute to the specification of neuronal type-specific dendrite 
patterns. A distinct dendrite morphology can be achieved by varying the levels of a single 
transcription factor, the specific expression of a transcription factor in a single type of neuron and 
combinatorial mechanisms that involve many transcription factors (Jan and Jan). For instance, the 
basic helix–loop–helix (bHLH) transcription factor Neurogenin 2 has a crucial role in the 
specification of dendrite morphology of pyramidal neurons in the neocortex: it promotes the 
outgrowth of a polarized leading process during the initiation of radial migration (Hand et al., 
2005). 
Moreover, developing dendrites of invertebrate and vertebrate neurons are responsive to extrinsic 
signals that can not only stimulate or inhibit outgrowth but can also act as cues for directional 
growth. For exemple, extrinsic factors such as neurotrophin 3, brain-derived neurotrophic factor 
(BDNF) and nerve growth factor (NGF) influence the dendrite morphology of cortical neurons 
(McAllister, 2002). 
Regarding the cell biological basis of dendrite morphogenesis, actin and microtubules are the major 
structural components that underlie dendrite morphology. Regulators of actin and microtubule 
dynamics therefore have important roles in dendrite morphogenesis. For instance, the Rho family of 
GTPases control a wide range of cytoskeletal rearrangements that affect spine morphogenesis and 
the growth and branching of dendrites in both vertebrate and invertebrate neurons (Leemhuis et al., 
2004; Newey et al., 2005; Chen and Firestein, 2007; Sfakianos et al., 2007). In addition, motors that 
mediate the transport of building blocks and organelles to dendrites are crucial for dendrite 
morphology (Satoh et al., 2008; Zheng et al., 2008). Dendrite growth and branching also require 
signalling molecules, building materials and organelles such as Golgi outposts and endosomes, 
which are transported by molecular motors along microtubules (Jan and Jan). 
At least three mechanisms contribute to the organization of dendritic fields: self-avoidance, tiling 
and coexistence. Dendrites of the same neuron avoid one another (self-avoidance) (Jan and Jan). 
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Dendrites of certain types of neurons —such as class III and class IV dendritic arborization neurons 
in D. melanogaster — avoid one another (tiling). Self-avoidance and tiling presumably ensure 
efficient and unambiguous coverage of the receptive field. Furthermore, dendrites of different 
neuronal types can cover the same region (coexistence) (Grueber et al., 2003) allowing the sampling 
of different types of information from the same receptive field. These three principles for 
organizing dendrites rely on different molecular mechanisms, for example, the immense diversity of 
D. melanogaster Down syndrome cell adhesion molecule (DSCAM) splice variants and the 
stochastic expression of a small subset of such isoforms in each dendritic arborization neuron 
ensure self-avoidance without compromising coexistence. Mammalian DSCAM also mediates self-
avoidance, indicating conservation of the function of this protein across species (Fuerst et al., 
2008).  
Furthermore, the size of dendritic arbors increases in proportion to animal growth, a phenomenon 
known as dendritic scaling. The final size of a dendritic arbor, once reached, is maintained 
throughout the lifetime of the neuron (Jan and Jan). Whereas some neurons such as the mammalian 
cerebellar granule cells do not alter their dendrites extensively during later stages of development, 
the dendrite size and complexity of other neurons such as Purkinje neurons grow in proportion to 
the animal’s growth (Jan and Jan). In addition, different types of neurons may scale their dendrites 
in different ways depending on their functional requirements. Once neuronal dendrites are 
sufficiently large to cover the dendritic field of the full-grown animal, it is important that dendritic 
coverage is maintained (Parrish et al., 2007). The molecular control of dendritic growth, scaling and 
maintenance is only beginning to be understood. Recently, kinase cascades (Dijkhuizen and Ghosh, 
2005; Jaworski et al., 2005; Jossin and Goffinet, 2007; Lee and Stevens, 2007; Parrish et al., 2009) 
and local translation in dendrites (Ye et al., 2004; Vessey et al., 2008) have been shown to be 
important for the control of dendrite size of certain mammalian neurons as well as D. melanogaster 
neurons (Jan and Jan). For instance, the PI3K–mToR kinase pathway, which is well known for its 
role in controlling cell size, has been shown to regulate dendrite size (Jaworski et al., 2005; Kumar 
et al., 2005). In addition, this pathway acts together with the mitogenactivated protein kinase 
(MAPK) cascade to regulate dendrite complexity and branching pattern (Kumar et al., 2005).  
Little is known about the mechanisms that are responsible for dendrite maintenance. Extended time-
lapse analyses of mouse cortical neurons have revealed that, following a period of juvenile 
plasticity during which neurons establish normal dendritic fields, dendrites become stable with most 
neurons maintaining their dendritic fields for the remainder of their lifespan (Grutzendler et al., 
2002; Holtmaat and Svoboda, 2009).  
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The vast majority of stable dendritic spines and filopodia-like protrusions on mature dendrites have 
synapses (Harris, 1999; Arellano et al., 2007). In vivo studies indicate that synaptic activity 
promotes dendritic arbor elaboration at early stages of brain development. At later stages of 
development, synaptic activity stabilizes dendritic structure. The different roles of synaptic activity 
with respect to structural plasticity probably reflect the regulated spatiotemporal expression of key 
components within signaling pathways (Cline, 2001). 
There are several sources and patterns of neuronal activity that drive brain development, which 
change as the neurons and circuits within the developing brain become established. One type of 
activity comes from waves of action potential activity in the retina, hippocampus, cortex and spinal 
cord, which are present during brain development (Feller, 1999).Waves of depolarization and 
associated calcium transients can provide activity-based signals both to the neurons participating in 
the wave directly and to the postsynaptic partners of those neurons. A second type of spontaneous 
activity, meaning activity that is not driven by afferent inputs, has been recorded in clusters or 
‘domains’ of neurons within limited periods of development (Yuste et al., 1995). Importantly, this 
type of activity is mediated by gap junctions and is therefore not blocked by the sodium-channel 
blocker, tetrodotoxin (TTX). Such activity may account for developmental events that are 
insensitive to TTX.  
A third potential source of activity for the developing cortex is the subplate—a transient population 
of neurons in the mammalian cortex that serves as an intermediate target for thalamic afferents. 
Neurons in the subplate extend axons into the developing cortical plate and form synaptic contacts 
with newly differentiating cortical neurons (Shatz, 1996). Fourth, patterned activity to the brain can 
be driven by sensory (Katz and Shatz, 1996) or motor (Inglis et al., 2000) inputs. Many cellular 
mechanisms also drive spontaneous activity in the spinal cord (Milner and Landmesser, 1999). 
In some cases, rather than decreasing dendritic growth, blocking synaptic activity paradoxically 
increases dendritic growth. For example, blocking glutamate receptors or L-type calcium channels 
increases dendritic growth of pyramidal and nonpyramidal neurons in cultured slices of ferret visual 
cortex (McAllister, 2000). Blocking NMDA receptors in neonatal ferrets in vivo also increases 
dendritic branching and spine formation in neurons in the lateral geniculate nucleus (Rocha and Sur, 
1995). There are evidences that AMPA receptor activation can also limit dendritic growth 
(Feldmeyer et al., 1999).  
In addition to a potent role for excitatory inputs, inhibitory inputs are also important in regulating 
dendritic growth (Sanes et al., 1992). Thus, the effects of neuronal activity on dendritic form may 
be site- and context-dependent (McAllister, 2000). 
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These paradoxical effects of decreased activity in enhancing dendritc growth are poorly understood 
(McAllister, 2000). Perhaps the simplest explanation for the widely differing effects of activity in 
these studies is that the cellular and molecular mechanisms of dendritic growth may differ between 
animal species and between brain regions (McAllister, 2000). 
Many evidences suggest that defects in dendrite development and/or maintenance could contribute 
to neurological and neurodevelopmental disorders such as schizophrenia, Down’s syndrome, fragile 
X syndrome, Angelman’s syndrome, Rett’s syndrome and autism (Miller and Kaplan, 2003; Bagni 
and Greenough, 2005; Pardo and Eberhart, 2007; Ramocki and Zoghbi, 2008; Walsh et al., 2008; 
Bourgeron, 2009). 
Long-term confocal microscopy imaging in adult rodents indicates that a large fraction of dendritic 
spines as well as complete dendritic arbors are stable for extended time periods of several months, 
and possibly years (Lin and Koleske, ; Holtmaat et al., 2005; Majewska et al., 2006). Moreover, 
individual synapses may last for the majority of an organism’s lifetime, possibly decades in the case 
of humans. Synapse and dendritic spine loss and dendritic atrophy are observed in the aging human 
brain (Lin and Koleske). Reductions in synapse number and dendritic arbor size are also associated 
with psychiatric illnesses, such as schizophrenia and major depressive disorder (MDD), as well as 
neurodegenerative diseases, such as Alzheimer’s disease (AD) (Flood, 1991; Anderton et al., 1998; 
Law et al., 2004; Stockmeier et al., 2004; Broadbelt and Jones, 2008). These reductions in synaptic 
connectivity are believed to be a major contributor to the altered mood and impaired perception and 
cognition that characterize these conditions. 
 
SYNAPSES 
Synapses are specialized cell junctions through which neurons can communicate to each other 
(Purves, 2008). 
There are two types of synapse: electrical and chemical. The first one is relatively rare and 
characterized by gap junction that let flowing of ionic current and secondary messengers across the 
two neurons. This structure allows a bidirectional transmission and a fast communication without 
the delay common in chemical synapses (Purves, 2008). 
Chemical synapses are the most diffused type in the central nervous system. They are composed, in 
order, by a pre-synaptic compartment, a synaptic cleft and a postsynaptic compartment; moreover 
recent studies includes astrocytes in the synapse (Tamminga et al.) (Fig.b). 
In this type of synapse, the communication is mediated by chemical agents, neurotransmitters, 
stored in vesicles of almost 40 nm diameter localized at the axon terminal of the presynaptic cell 
(Sheng and Hoogenraad, 2007). When an action potential in the presynaptic cell reaches an axon 
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terminal, it induces a localized rise in the level of Ca2+ in the cytosol. This, in turn, causes some of 
the vesicles to fuse with the plasma membrane, releasing their contents into the synaptic cleft, the 
narrow space between the cells (about 20-25 nm) (Lodish, 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. b. A tripartite synapse: When neurotransmitters are released from the presynaptic terminal of a neuron, astrocytic 
receptors are thought to be activated, leading to a rise in calcium ions in the astrocyte and the release of various active 
substances, such as ATP, which act back on neurons to either inhibit or enhance neuronal activity. Astrocytes also 
release proteins, which control synapse formation, regulate presynaptic function and modulate the response of the 
postsynaptic neuron to neurotransmitters (Allen and Barres, 2009). 
 
 
The neurotransmitter (mainly glutamate for excitatory and GABA for inhibitory synapses in CNS) 
will reach and bind to the receptors on the post-synaptic membrane causing their opening and the 
incoming of ions (sodium and calcium for excitatory synapses or chlorum for inhibitory one) in the 
intracellular compartment. So, the effect on the post synaptic neuron (depolarization or 
iperpolarization) can determine the difference between excitatory and inhibitory synapse. Moreover 
excitatory synapses have a zone enriched of receptors to receive neurotransmitters, that is called 
post synaptic density (PSD) for its electron dense thickening of membrane, well visible at electron 
microscope, so defined asymmetric, instead inhibitory ones are defined symmetric for similar 
thickening of the pre e post-synaptic membrane (Sheng and Hoogenraad, 2007). 
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The presynaptic compartment is highly organized to allow the fusion of synaptic vesicles and the 
release of neurotransmitters in response to Ca2+ influx and presents a complex protein machinery to 
do so (Frank et al.). Synaptic vesicles consist of a lipid membrane with interspersed proteins that 
can enable Ca2+-dependent responses for the release of neurotransmitters into the synaptic cleft. 
Among other things, synaptic vesicles must be trafficked to the presynapse, loaded with 
neurotransmitters, and docked at the site of release before fusion with the cell membrane. After the 
fusion with the cell membrane, synaptic vesicles must then be endocytosed to allow for the refilling 
with neurotransmitters and so another cycle of neurotransmitter delivery via synaptic vesicles can 
begin (Sudhof, 2004). Some of the proteins involved in this synaptic vesicles cycle and  dynamics 
are Glutamate decarboxylase-65 (GAD65), vesicular glutamate transporter (VGLUT), vesicular 
gamma-Aminobutyric acid (GABA) transporter (VGAT), Synapsin (Syn), Synaptotagmin (SYT), 
Synaptophysin (Syp) and Cask. For example, GAD65 is involved in the (local) synaptic synthesis 
of GABA, whereas VGLUT and VGAT are involved in the loading of synaptic vesicles. Instead, 
Syns are involved in the anchoring of synaptic vesicles to the presynaptic scaffold, as well as the 
Ca2+-dependent release of synaptic vesicles from the scaffold, Syp appears to be relevant for the 
endocytosis of synaptic vesicles, and adaptor proteins like Cask are indirectly involved in the 
anchoring synaptic vesicles at the presynaptic release site (Kwon and Chapman, ; Sudhof and Rizo, 
; Kanaani et al., 2002; Tabuchi et al., 2002). 
 
DENDRITIC SPINES AND PSD 
Dendritic spines are small (typically 0.5–2 µm in length) actin-rich protrusions that house the 
essential excitatory postsynaptic components, including the post-synaptic density (PSD), actin 
cytoskeleton, and a variety of “supporting” organelles like mitochondria. Spines occur at a density 
of 1–10 spines per µm of dendrite length on principal neurons, and they receive most of the 
excitatory synapses in the mature mammalian brain (Sala and Segal). 
Typical spines have a bulbous head (receiving a single synapse) connected to the parent dendrite 
through a thin spine neck.  
Dendritic spines are highly heterogeneous structures that show dynamic motility, especially during 
development. Their number, size, and shape undergo plastic changes correlated with long-term 
modifications of synaptic strength like certain form of synaptic plasticity (LTP and LTD) and 
interneuronal connectivity (Fig. d). Spine shape has been categorized as “mushroom,” “thin,” or 
“stubby,” (Sheng and Hoogenraad, 2007) but EM studies show a continuum between these 
categories (Fig. c).  
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Fig. c. A schematic representation of filopodium and different types of dendritic spines (Yuste and Bonhoeffer, 2004). 
 
 
Synapse formation and stabilization needs filopodia, structures present only in developing dendrites 
(or in adults ones, in pathological condition), distinguishable only on their morphological features. 
Filopodia is an exploratory shape for spines that can be determinant to the final form of spine. The 
aim of this structure is to explore and establish first contact with axons (Li and Sheng, 2003) (Yuste 
and Bonhoeffer, 2004). There are evidences that different spine shapes and sizes reflect different 
developmental stages and/or altered strength of synapses. Imaging experiments indicate that the 
volume of spine heads can increase with stimuli that strengthen synapses and can decrease with 
stimuli that weaken synapses. Spines with large heads are generally stable, express large numbers 
of AMPARs, and contribute to strong synaptic connections. By contrast, spines with small heads 
are more motile, less stable, and contribute to weak synaptic connections.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. d. Changes in actin polymerization and spine morphology with LTP and LTD: (a) LTP (Long Term Potentiation) is 
associated with a shift of actin equilibrium toward F-actin (linear chains of monomeric G-actin) in spines, enlargement 
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of the spine head, and recruitment of more AMPA receptors to the postsynaptic membrane. (b) By contrast, LTD (Long 
Term Depression) stimulation shifts the equilibrium toward actin depolymerization, resulting in shrinkage or loss of 
spines (Tada and Sheng, 2006). 
 
 
For instance, in studies on mouse brain, it is evident that a large fraction of mushroom spines are 
persistent, with lifetimes up to many months (Sheng and Hoogenraad, 2007). The size, shape, 
motility, and stability of dendritic spines depend largely on actin, the primary cytoskeleton within 
spines. A complex network of regulatory proteins, including the Rho family GTPases, controls actin 
arrangement and spine morphogenesis. 
Since dendritic spines are thought to represent a morphological correlate of neuronal plasticity, 
altered spine morphologies may underlie or contribute to cognitive deficits seen in intellectual 
disability (von Bohlen Und Halbach). 
The Post-Synaptic Density (PSD) is a specialized region at the excitatory post-synaptic 
compartment that is enriched in receptors, scaffold proteins and secondary messengers. PSD is 
important for signal transduction and synaptic plasticity (Sheng and Kim, 2002) (Fig. e). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. e. Molecular organization of the PSD of excitatory synapses: schematic diagram of the major proteins of the PSD, 
with protein interactions indicated by direct contacts or overlaps between the proteins (Sheng and Kim). 
 
 
The postsynaptic compartment is highly organized to enable a response to neurotransmitter binding 
which includes (but is not limited to) a neurotransmitter-dependent influx of ions and a 
neurotransmitter-dependent induction of signaling cascades. For example, the postsynapse harbors 
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neurotransmitter receptors like the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 
(AMPAR), an ionotropic GluRs (Dingledine et al., 1999) (Sarto et al., 2002) and metabotropic 
neurotransmitter receptors like mGluRs which diversify the response of the postsynapse to 
neurotransmitters.  
Additionally, the postsynapse exhibits an extensive scaffold which links neurotransmitters receptors 
with the cytoscelleton and signalling machinery; some prominent members of this scaffold include 
Postsynaptic Density protein 95 (PSD-95), Shank and Homer1.  
Scaffold proteins are involved in the assembly of synaptic complex by linking different players by 
their protein-protein interaction domain. One of most studied family of scaffold protein in PSD is 
the MAGUK family (Membrane-associated Guanylate Kinase), that includes PSD-95 (o SAP90), 
SAP102, SAP 97, Chapsyn 110 (o PSD93) and p55 (Sala et al., 2001). The most studied MAGUK 
is PSD-95 because of its role in organization of signaling complexes at PSD. PSD-95 has the typical 
structure of MAGUK, including the three PDZ domains, an SH3 domain and a Guanylate Kinase 
dead domain (GK domain). PSD-95 can be a central organizer for PSD: it’s involved in the 
recruitement of diverse protein to sites of synaptic adhesion, in promotion of trans-synaptic 
signaling and in coupling neuronal activity to changes in synaptic adhesion (Kreutz and Sala). 
Another well-know family of scaffold protein massive present in PSD is ProSAP/Shank family. It 
consists by three members: Shank1, Shank2 and Shank3, all enriched in PSD and localized at the 
interface between membrane receptors and cytoskeletal elements (Kreutz and Sala). Shank proteins 
can interact directly or via adaptor proteins with glutamatergic receptors.  
GKAP/SAPAP is a family of adaptor proteins that can bind Shank PDZ via their C-terminal domain 
and MAGUKs such as PSD-95 via their N-terminal domain. Shank1 and 3 can recruit Homer1b via 
their proline-rich domain; Homer1b, in turn, clusters with mGlu1 and 5 via its C-terminal and 
further interacts with IP3R (inositol triphosphate receptor) of the spine apparatus (Sala et al., 2001).  
In the postsynaptic compartment there are also cell adhesion molecules like neuroligin-1 (NLGN1), 
which are linked to presynaptically located cell adhesion molecules like neurexins and, finally, the 
postsynaptic compartment also exhibits many signalling proteins, among them the most important 
are the Ca2+/Calmodulin-dependent kinase II (CaMKII) and neuronal nitric oxide synthases 
(McAllister, 2002; Sfakianos et al., 2007; Satoh et al., 2008; Zheng et al., 2008).  
 
DENDRITIC AND SYNAPSE ARCHITECTURE AND NEUROLOGICAL DISORDERS 
Thanks to last years studies, it is clear that alterations in neuronal structure, like alterations in 
number or length of dendritic branches, or in number and shape of dendritic spines, are associated 
with intellectual disability (ID) or autism.  
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Given the functional relationship of PSD proteins to synapse development, structure, and function, 
it is not surprising that mutations in many PSD proteins are associated with human neurologic and 
psychiatric disease (Bayes et al.). Autism spectrum disorders have been linked to mutations in 
genes encoding Shank1, Shank2 and Shank3, PSD-93, DLGAP2/SAPAP2, and SynGAP1, as well 
as synaptic adhesion molecules neuroligin 3, neuroligin 4, and neurexin 1 (Berkel et al., ; Pinto et 
al., ; Durand et al., 2007; Sudhof, 2008). Mutations in SAPAP3 are associated with obsessive 
compulsive disorder (Welch et al., 2007; Zuchner et al., 2009).  
Consistent with the necessity of appropriate dendritic architecture for higher order brain functions, 
including learning and memory, deficiencies in the architecture of dendrites have been observed in 
a variety of neurodevelopmental, neurodegenerative and neuropsychiatric disorders (Kulkarni and 
Firestein). For example, decreased dendritic branching in CA1 and CA4 hippocampal neurons 
occurs in patients with autism and neurons from patients with Rett syndrome. Similarly, altered 
dendritic arborization and decreased expression of glutamate receptors have been observed in CA3 
hippocampal neurons of patients with schizophrenia (Kolomeets et al., 2007). Specific dendritic 
alterations are seen in cortical neurons in those with Rett syndrome. Decreased dendrite number 
have also been observed in patients with Alzheimer’s Disease (Couch et al.), and Down Syndrome 
(Dierssen et al., 2003). In addition to the neurodevelopmental and neurodegenerative disorders, 
other neurological disorders may be associated with alterations in the dendritic arbor that 
compromise higher order functions, including cognition. For example, recurrent seizures during 
development in mice lead to a suppression of the growth of dendrites in the CA1 region (Casanova 
et al.) and may thus contribute to the cognitive deficits observed in childhood epilepsy. Thus, an 
abnormality in the dendritic arbor is a common theme seen in disorders of the central nervous 
system and these aberrations may be directly linked to deficiencies in higher order brain functions 
(Arikkath). 
 
INTELLECTUAL DISABILITY 
Intellectual disability (ID) affects about 2% of population of industrialized country. ID is defined by 
3 main criteria: intelligent quotient lower than 70 (the mean in the population is 100), deficit in  
adaptive behavior, including autism spectrum disorders (ASD) in several patients and onset before 
18 years old (Verpelli et al.). 
ID can be caused by non-genetic factors, like infecions, prematurely birth, perinatal anoxia, etc., 
that represents almost 50% of cases, meanwhile the other cases are attributable to genetic factors. 
Genetic causes are many and different; they can be grouped in three big panel: one includes genes 
involved in metabolic pathway common between different organs or cell type, the second comprises 
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defect in nervous system development with alteration in neuron interaction and the last includes all 
genes that causes only ID, named non-syndromic or non-specific ID. Moreover genes for ID can be 
associated to chromosome X or autosomic chromosome (Verpelli et al.). 
More than 50% of the ID-related proteins that are not transcription or chromatin-remodeling factors, 
are clearly present in the pre- or post-synaptic compartments, implicated in synaptic functions by 
regulating synapse formation, actin cytoskeleton rearrangement (i.e. OPHN1, PAK3, and 
ARHGEF6), or synaptic plasticity. The synapse-related proteins associated with ID can be 
separated into two groups, one that localizes fully at synapses and whose deletions and mutations 
directly impede with synaptic formation, and a second cluster that indirectly controls neuronal 
development and synapse formation by regulating synthesis and degradation of major synaptic 
proteins or the synaptic actin cytoskeleton assembly or disassembly. Another recurrent feature is the 
high expression of altered gene in hippocampus, a brain region strongly involved in learning and 
memory (Verpelli et al.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. f. Signaling pathways and possible treatments associated with ASD. Molecules whose mutations or polymorphisms 
are associated with ASD are indicated in red. Stimulations and inhibitions are indicated by red and blue arrows, 
respectively. Possible treatments and their target molecules are indicated by red texts in orange boxes. SynGAP1,which 
directly interacts with PSD-95, could not be placed next to PSD-95 for simplicity (Won et al.). 
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Unfortunately, only two medicines are currently approved for ASD by US FDA; risperidone 
(Risperdal®) and aripiprazole (Abilify®), which act as dopamine/5-HT receptor antagonists 
(McPheeters et al.). These drugs are useful for correcting irritability and stereotypy, but not 
sociability defects. Recently, a number of candidate ASD medications for treating social 
abnormalities have been suggested (Won et al.) (Fig. f).  
Positive allosteric modulators of mGluR5 receptors were first developed to alleviate symptoms of 
schizophrenia (Gregory et al.) augmenting NMDAR signaling via mGluR potentiation (Stefani and 
Moghaddam, ; Uslaner et al., 2009). A large number of mGluR5 allosteric modulators have been 
developed of these, CDPPB, in particular, has been examined in various behavioral assays and 
model animals (Stefani and Moghaddam, ; Won et al., ; Kinney et al., 2005; Uslaner et al., 2009). 
These published results suggest that mGluR5 positive allosteric modulators have the potential to 
improve cognitive impairments associated with brain disorders including schizophrenia and autism. 
D-cycloserine is a high-affinity partial agonist of NMDA-coupled, strychnine-insensitive glycine 
receptors.  Putative effects of D-cycloserine on ASD have been suggested by previous studies 
(Blundell et al., ; Posey et al., 2004). Moreover, D-cycloserine partially rescues social deficits of 
Shank2−/− mice, supporting the role of NMDAR functionality in autism (Won et al.). 
Clonazepam, a type of benzodiazepine, is a positive allosteric modulator of GABAA receptors that 
exerts sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxing effects (Rudolph and 
Knoflach). Similar to the action of mGluR positive allosteric modulators, clonazepam potentiates 
GABA signaling only when GABAA receptors are bound by their endogenous ligand, GABA. 
Published results indicate that Clonazepam is able to normalize disrupted E-I balance in ASD 
mouse models and that is a promising strategy for treating symptoms of ASD (Won et al.). 
Synaptic protein synthesis is stimulated by local mRNA translation, a process that depends on 
group I mGluR activation. FMRP, encoded by the Fmr1 gene, is a repressor of mRNA translation; 
thus, mGluR-mediated protein synthesis could be enhanced in the absence of FMRP. Therefore, 
attempts have been made to correct fragile X syndrome by suppressing abnormally enhanced 
mGluR5-dependent synaptic plasticity and protein synthesis (Yan et al., 2005). In line with this, 
mGluR negative allosteric modulators are now in clinical trials for fragile X syndrome patients 
(Krueger and Bear). 
Rett syndrome is an X-linked neurological disorder caused by mutations in the MeCP2 gene. 
MeCP2 is a transcriptional repressor and activator, which binds widely across the genome and 
influence a large number of genes (Chahrour et al., 2008). One of the best characterized targets of 
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MeCP2 is BDNF, a neurotrophic factor that regulates neuronal development and synaptic plasticity 
(Greenberg et al., 2009). Moreover, restoring Bdnf expression through ampakine administration 
alleviates respiratory problems of MeCP2 mutant mice (Ogier et al., 2007). Another growth factor 
associated with Rett syndrome is insulin-like growth factor 1 (IGF-1). IGF-1 is a polypeptide 
hormone with structural similarity to insulin. While it has a profound effect on overall cell growth, 
it also plays an important role in regulating neuronal functions by promoting axonal outgrowth 
(Ozdinler and Macklis, 2006), neuro- and synaptogenesis (O'Kusky et al., 2000), and activity-
dependent cortical plasticity (Tropea et al., 2006). IGF-1 activates Ras-MAPK and PI3K-Akt 
pathways (Fernandez et al.), signaling cascades that are also activated by BDNF. The therapeutic 
utility of IGF-1 in Rett syndrome was originally suggested by Mriganka Sur and coworkers, who 
reported that lethality, hypoactivity, and respiratory problems of MeCP2-null mice are partially 
rescued by IGF-1 treatment in association with normalization of impaired spine density, synaptic 
transmission, and cortical plasticity (Tropea et al., 2006). IGF-1 also reverses the reduction in 
excitatory synapse number and density of neurons derived from Rett patients (Marchetto et al.). 
Rapamycin is an immunosuppressant that strongly binds to FK506-binding protein (FKBP); this 
complex then binds and inhibits mTOR, a serine/threonine kinase implicated in transcription, 
cytoskeleton dynamics, ubiquitin-dependent protein degradation, autophagy, and membrane 
trafficking (Dennis et al., 1999). Perturbations in mTOR signaling have significant impacts on 
normal brain functions. The therapeutic utility of rapamycin in ASD was suggested in 2008 based 
on studies in Tsc2+/− mice (Ehninger et al., 2008). The mTOR pathway is associated with TSC 
because TSC1 and TSC2 are upstream inhibitory regulators of mTOR activity (Han and Sahin). In 
this study, the learning and memory deficits, lethality, aberrant brain overgrowth, and altered 
synaptic plasticity of Tsc2+/− mice were ameliorated by acute treatment with rapamycin. The social 
dysfunction and behavioral inflexibility of Purkinje cell-specific Tsc1 mutant mice were also 
improved by rapamycin (Tsai et al.), further suggesting that rapamycin may be useful in reversing 
core symptoms of autism. 
Oxytocin is associated with various social behaviors including affiliation, maternity, aggression, 
and pair bonding (Caldwell, ; Feldman). Given the prominence of oxytocin in the regulation of 
social behavior, the association of oxytocin with autism pathogenesis has been extensively 
examined. Several SNPs of OXTRs are associated with ASD (Yrigollen et al., 2008) (Liu et al.). 
Oxtr knockout mice display autistic-like behaviors; they emit fewer USVs upon social isolation, 
show defects in social recognition and discrimination, and are less aggressive (Crawley et al., 
2007). Supporting the pharmacotherapeutic potential of oxytocin, nasal administration of oxytocin 
improves social interactions and communications (Andari et al., ; Kosaka et al.), reduces repetitive 
INTRODUCTION 
 
20 
behaviors (Hollander, ; Hollander et al., 2003), and enhances social cognition (Hollander et al., 
2007) in autism-affected individuals. 
Moreover, NMDAR antagonists including amantadine and its close analogue memantine are now in 
clinical trials for autistic patients (Spooren et al.).  
Severe forms of ID are often attributable to mutations of a single gene on the X chromosome 
(Verpelli et al., ; Chechlacz and Gleeson, 2003). X-linked ID was first discovered in 1938 by 
Penrose: analyzing 1280 patients institutionalized, he saw a higher percentage of male with ID (20-
25%) than female. The association with chromosome X was definitively confirmed in 1970 by 
Lehrke using genetic mapping (Lehrke, 1972; Carter, 2002). 
The majority of the XLID are attributable to the Fragile X and Rett syndromes, however deletions 
and mutations of several other genes on chromosome X have been found strongly associated with 
ID (Verpelli et al.). Interleukin-1 receptor accessory protein like 1 (IL1RAPL1) gene is localized on 
X chromosome and a number of mutations in this gene (IL1RAPL1; OMIM 300206) have been 
found in patients with cognitive impairments ranging from non syndromic ID to ASD (Barone et 
al., ; Behnecke et al., ; Franek et al., ; Koh et al., ; Mignon-Ravix et al., ; Youngs et al., ; Carrie et 
al., 1999; Bahi et al., 2003; Tabolacci et al., 2006; Piton et al., 2008). There is also a case of startle 
epilepsy associated with IL1RAPL1 gene deletion (Dinopoulos et al.). 
 
IL1RAPL1 AND ITS INTERACTORS 
The IL1RAPL1 protein belongs to a new Toll/IL-1 receptor family and shares 52% homology with 
the IL-1 receptor accessory protein (IL-1RacP) and it is structurally formed by three extracellular 
Ig-like domains, a transmembrane domain, and an intracellular Toll/IL-1R homology domain (TIR 
domain). Il1rapl1 gene extents for 1.3 Mbases on chromosome X in Xp22.1–21.3 region (Carrie et 
al., 1999). cDNA is composed by 11 exons for 3,6 Kbasi total (NM_014271). 
 
 
 
 
 
 
 
Fig. g. Schematic representation of IL1RAPL1 domains: the signal peptide (SP), the three IG-like domains, the 
transmembrane segment (TM), the TIR domain, the specific domain of IL1RAPL1 and the putative PDZ binding motif.  
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 Il1rapl1 gene encodes for a transmembrane protein of 696 aminoacids with a molecular weight of 
approximately 80 KDa. IL1RAPL1 has a signal peptide of 18 aa with a cleavage site at TQS/LK 
predicted site and a 17 amino acid transmembrane segment that divides the protein into two 
domains: a 359 amino acid extracellular and a 319 amino acid cytoplasmic domain. The 
extracellular domain is rich in cysteine residues that are responsible for formation of three Ig-like 
domains (Fig. g).  
Another member of this class is IL1RAPL1 homologue, IL1RAPL2 (or TIGIRR-1, three 
immunoglobulin domain-containing IL-1 receptor-related) that shares 63% amino acid identity with 
IL1RAPL1 (Born et al., 2000). 
The TIR domain, typical of human superfamily of IL-1/Toll receptor, has 150-200 conserved 
aminoacid residues and it is important to mediate protein-protein homophilic interaction in innate 
immunitary response pathway (Radons et al., 2003). Although the homology, IL1RAPL1 and 
IL1RAPL2 seem not to be involved in inflammatory response (NF-kB-dependent signaling 
pathway) and are unable to bind any isoform of IL-1 (Born et al., 2000). 
IL1RAPL1 transcripts are expressed at a low level in fetal and adult brain: the first detectable 
transcript in mouse brain is at E10.5 with an increased level at E12.5 that remains the same in adult 
life. The high level of expression of IL1RAPL1 in brain areas that are involved in memory 
development, such as hippocampus, dentate gyrus and entorhinal cortex, suggests that this gene 
may have a specialized role in physiological processes underlying memory and learning abilities 
(Carrie et al., 1999; Gao et al., 2008). It is also highly expressed in mouse olfactory bulb and 
tubercule, which may be correlated with the evolutionary trend implicating the predominant role of 
olfactory perception in behavioural development in lower mammals (Carrie et al., 1999). Analysis 
of the other tissues reveal a transcription of IL1RAPL1 in heart, brain, ovary, skin, and a lesser level 
of expression in tonsil, fetal liver, prostate, testis, small intestine, placenta, and colon. Expression 
was not detected in spleen, lymphnode, thymus, bone marrow, leukocytes, lung, liver, skeletal 
muscle, kidney, or pancreas (Born et al., 2000).  IL1RAPL1 expression is very low compared with 
that of VGLUT1 or GAD67 (Houbaert et al.). Higher expression levels of IL1RAPL1 mRNA were 
recurrently seen in olfactory bulbs and in dentate gyrus of the hippocampus. In the amygdaloid 
complex, expression spans all excitatory (basolateral amygdala) and inhibitory (intercalated cells 
and central amygdala) regions homogeneously (Houbaert et al.).  
The mouse homologue of human IL1RAPL2, is mainly expressed in skin and liver (Born et al., 
2000). Although the low level expression of IL1RAPL2 in brain, it has a complementary pattern of 
expression and is mainly expressed in the cingulum, colliculus and lateral substantia nigra. These 
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results suggest that both genes may have similar functions, but in different brain structures (Bahi et 
al., 2003). 
The level of expression of IL1RAPL, was significantly up-regulated following kainite treatment and 
LTP induction,  suggesting a possible role for this gene in activity-dependent brain plasticity (Boda 
et al., 2002). 
About IL1RAPL1 protein localization in synapse, immunocytochemical staining with anti-
IL1RAPL1 antibody shows that endogenous protein clusters are distributed in the dendrites of 
cultured cortical neurons and partially overlapped with postsynaptic Shank1 clusters (Pavlowsky et 
al.); meanwhile the overexpression of IL1RAPL1 increases the staining signals of excitatory 
postsynaptic marker Shank2 (Yoshida et al.). A comparison between Shank proteins clusters signal 
and synaptophysin (a marker of presynaptic compartment) clusters signal underlines a predominant 
postsynaptic localization of IL1RAPL1 (Pavlowsky et al.). Moreover there is a high level of 
colocalization between IL1RAPL1 and PSD-95, instead it is only partial with VGAT (a marker of 
inhibitory synapse), so IL1RAPL1 is mostly localized in excitatory synapses (Pavlowsky et al.).  
 
In vitro, IL1RAPL1 plays a role in presynaptic differentiation and dendritic spine formation and 
stabilization in cortical and hippocampal neurons. siRNA against IL1RAPL1 can reduce number of 
dendritic protrusion in neuron culture (Yoshida et al.) and IL1RAPL1 overexpression in neurons 
increases VGLUT1 (an excitatory presynaptic marker) staining and dendritic spine number (but not 
the length or the width of the heads) (Pavlowsky et al., ; Valnegri et al.). Furthermore, the increase 
in synapse number is associated with an increase of miniature excitatory postsynaptic potential 
(mEPSC) frequency (Pavlowsky et al.).  
In vivo, the role of IL1RAPL1b, an orthologous of IL1RAPL1, was analyzed in olfactory sensory 
neurons of zebrafish. Antisense morpholino oligonucleotide against IL1RAPL1b suppressed both 
synaptic vesicle accumulation and axon terminal remodeling. Consistently, the overexpression of 
IL1RAPL1b stimulated synaptic vesicle accumulation. Swapping the carboxyl-terminal domain of 
IL1RAPL1b with that of mouse IL-1 receptor accessory protein abolished the stimulatory effect. On 
the other hand, a substitution mutation in the TIR domain suppressed the morphological remodeling 
of axon terminals. Thus, the regulation of synaptic vesicle accumulation and subsequent 
morphological remodeling by IL1RAPL1b appeared to be mediated by distinct domains (Yoshida 
and Mishina, 2008). 
In mouse model, the loss of IL1RAPL1 in KO mice lead to a slight but significant reduction of 
spine density, especially in the cortex (Yasumura et al.) and in the CA1 region of hippocampus 
(Pavlowsky et al.), meanwhile the architecture of this contacts is unchanged (spine shape, 
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presynaptic structure, …) and there isn't any difference in number or organization of inhibitory 
synapse (Pavlowsky et al.). Functionally, the reduction of excitatory synapse number results in a 
little, not significant reduction of mEPSC and LTP impairment only with a paradigm of theta burst 
stimulation (LTP for high frequency stimulation is comparable to WT mice). Data of behavioral 
studies shows that IL1RAPL1 KO male mice show deficits in spatial memory (Pavlowsky et al.) 
and altered cued fear memory formation (Houbaert et al.). In addition, the acquisition and retention 
of spatial reference memory, the spatial working memory and long-term fear memories are impaired 
in IL1RAPL1 KO mice (Yasumura et al.). Social interaction is increased in IL1RAPL1 KO mice 
and their motor coordination is improved, but the motor learning ability is comparable with WT 
mice (Yasumura et al.). Finally, IL1RAPL1 KO mice show enhanced locomotor activity and 
reduced anxiety-like behaviours (Yasumura et al.). 
Abnormalities in the formation and function of cerebellar circuitry potentially contribute to 
cognitive deficits in humans. In IL1RAPL1-deficient mice the absence of IL1RAPL1 causes a 
transient disinhibition of deep cerebellar nuclei neurons and upstream, in the cerebellar cortex, 
developmental perturbations have been found in the activity level of molecular layer interneurons.  
Thus, IL1RAPL1 exerts a key function during cerebellar development in establishing local 
excitation ⁄ inhibition balance (Gambino et al., 2009). Interestingly, it was seen that more than 90% 
of autistic patients exhibit cerebellar abnormalities (Piton et al., 2008) thus this results provide an 
additional insight into physiological defects in patients. 
In contrast to the other members of the Toll/IL-1 receptor family, IL1RAPL1 has 150 additional 
amino acids  at the C-terminus, that interact with the neuronal calcium sensor-1 (Bahi et al., 2003),  
thus regulating type voltage-gated calcium channel activity in PC12 cells and in neurons (Gambino 
et al., 2007).  
The stable expression of IL1RAPL1 in PC12 cells induces a specific silencing of N-type voltage-
gated calcium channels (NVGCC) activity that explains a secretion deficit observed in these cells. 
Importantly, this modulation of VGCC activity is mediated by NCS-1. Indeed, a specific loss-of-
function of N-VGCC was observed in PC12 cells over-expressing NCS-1, and a total recovery of 
N-VGCC activity was obtained by a down-regulation of NCS-1 in IL1RAPL1 cells. Because both 
proteins are highly expressed in neurons, these results suggest that IL1RAPL1-related ID could 
result from a disruption of N-VGCC and/or NCS-1-dependent synaptic and neuronal activities 
(Gambino et al., 2007). 
Our laboratory showed that the first and second PDZ domains of PSD-95 bind to the C-terminal tail 
of IL1RAPL1 that is characterized by a PDZ putative binding motif (Pavlowsky et al.). Using gain- 
and loss-of-function experiments in neurons, we demonstrated that IL1RAPL1 regulates the 
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synaptic localization of PSD-95 by controlling c-Jun terminal kinase (JNK) activity and PSD-95 
phosphorylation (Pavlowsky et al.).   
IL1RAPL1 over-expression in hippocampal primary cultured neurons increases the spines number 
without affecting morphology (Pavlowsky et al., ; Valnegri et al.). This effect requires both 
extracellular and intracellular domains of IL1RAPL1 and it is not dependent on PSD-95 interaction: 
in hippocampal primary cultured neurons over-expressing IL1RAPL1∆8 (IL1RAPL1 deleted 
mutant lacking the PSD-95 binding domain (Pavlowsky et al.)) the effect on spines is still present 
and the over-expression of IL1RAPL1∆C, lacking most of the C-terminal region (Carrie et al., 
1999), or ∆N (Behnecke et al., ; Carrie et al., 1999) results in a spine number similar to the control, 
demonstrating the role of both N-term and C-term regions of IL1RAPL1 in spine formation 
(Pavlowsky et al., ; Valnegri et al.). Interestingly, the extracellular domain is sufficient to increase 
excitatory pre-synaptic compartment recruitment (intensity level of VGLUT1 staining) instead the 
inhibitory pre-synaptic excitatory staining (using VGAT as marker) is unchanged. Similar data was 
shown for IL1RAPL2 overexpression (Valnegri et al.).  
These data suggest that multiple interactors are needed to induce spine formation. The C-terminal 
tail of IL1RAPL1, in particular TIR domain and the last 150 aa, can recruit RhoGAP2, meanwhile 
the extracellular domain can bind to receptor tyrosine phosphatase δ (PTPδ), a member of LAR-
RPTP family, suggesting a role of IL1RAPL1 and IL1RAPL2 as synaptic cell adhesion proteins 
(Valnegri et al.). 
RhoGAP2 interaction with IL1RAPL1 has been demonstrated in our laboratory through a yeast two 
hybrid assay on a human fetal brain cDNA library (Valnegri et al.). 
RhoGAP proteins increase the intrinsic GTPase activity to inactivate the RhoGTPase switch and 
guanine-nucleotide dissociation inhibitors (GDIs) (Sala and Segal, ; Jaffe and Hall, 2005). Rho 
proteins have been implicated in different aspects of neuronal morphogenesis, including dendritic 
arbor development and spine morphogenesis: for example, Rac1 positively regulates and RhoA 
negatively regulates dendritic spines morphogenesis (Sala and Segal, ; Govek et al., 2004).  
RhoGAP2 is expressed in the cortex, the cerebellum and the hippocampus of adult mice and in the 
cortex and hippocampus in mice during development. RhoGAP2 is also present in the synaptosomal 
fraction. Endogenous RhoGAP2 mostly co-localizes with PSD-95 and Shank1 proteins which are 
markers of excitatory post-synapses. The over-expression of RhoGAP2 in hippocampal neurons 
primary culture induces both excitatory synapse and dendritic spine formation. However, the over-
expression of a RhoGAP2 mutant that does not bind to IL1RAPL1 causes a drastic change in spine 
shapes which are converted to filopodia like shape. Moreover,  the endogenous RhoGAP2 staining 
is increased at synapses when IL1RAPL1 is over-expressed (Valnegri et al.). 
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The interaction of IL1RAPL1 with RhoGAP2 is required to induce dendritic spine formation. 
Interestingly, we found that blocking the IL1RAPL1/PTPδ interaction abolished RhoGAP2 
recruitment at excitatory synapses, suggesting that IL1RAPL1 is involved in a novel trans-synaptic 
signaling pathway that regulates excitatory synapse and dendritic spine formation (Valnegri et al.) 
(Fig. h). 
We also showed that the extracellular domain of IL1RAPL1 induces excitatory synapse formation 
by binding PTPδ, which is localized at the pre synaptic terminal (Valnegri et al.). Interestingly it 
was also demonstrated that the extracellular domain of IL1RAPL1 interacts only with particular 
splice variants of PTPδ (Yoshida et al.).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. h. The synaptic IL1RAPL1 complex (Carlo Sala) 
 
PTPδ is a member of LAR-RPTPs family, a subfamily of receptor protein tyrosine phosphatase 
(RPTP) type IIa, localized on synaptic membrane with a role in axon outgrowth and guidance 
(Dunah et al., 2005; Sajnani et al., 2005; Yang et al., 2005).  
Mutations in chromosome locus of PTPδ (9p24.3-p23) have been associated with restless legs 
syndrome (Schormair et al., 2008), cancer (Hendriks and Pulido, ; Solomon et al., 2008), autism 
spectrum disorder (Pinto et al.), attention-deficit hyperactivity disorder (Elia et al.), bipolar disorder 
and schizophrenia (Malhotra et al.). 
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PTPσ and LAR are the other vertebrate members of LAR-RPTPs family. LAR-RPTPs are encoded 
by three independent genes and they share 66% of amino acid identity (Pulido et al., 1995). 
LAR-RPTPs are composed by three cell adhesion immunoglobulin-like (Ig) and numerous 
fibronectin III (FNIII) domains (maximum eight), suggesting a role of LAR-RPTPs in cell-cell and 
cell-matrix interactions and therefore in synaptic adhesion and synapse organization. The 
intracellular region is composed by two protein tyrosine phosphatase (PTP) domains, one, the 
proximal to membrane, with a strong catalytic activity (D1), the other with a residual or no catalytic 
activity (D2) (Pulido et al., 1995; Wallace et al., 1998; Blanchetot et al., 2002; Gonzalez-Brito and 
Bixby, 2006). It was hypothesized that LAR-RPTPs exist as dimers when inactive and monomerize 
on ligand binding, resulting in activation of PTP (Um and Ko). LAR-RPTPs can interlink distinct 
tyrosine phosphorylation signaling pathways, mostly by dephosphorylating elements of these 
pathways. For example there is an interaction between PTPσ D1 domain and PTPδ D2 domain that 
has a negative regulatory function (Wallace et al., 1998). 
LAR-RPTPs are expressed in different tissue; in brain, they are involved in trans-synaptic (both 
excitatory and inhibitory) complexes with three general functions in synaptic organization. One is 
to mediate cell–cell adhesion at synapses. For instance, the full-length extracellular domain (ECD) 
of PTPδ functions as a ligand to promote cell adhesion and neurite outgrowth (Wang and Bixby, 
1999; Gonzalez-Brito and Bixby, 2006). The second one is to mediate presynaptic differentiation, 
local recruitment of synaptic vesicles and release and recycling machinery (a form of retrograde 
synaptogenic signaling triggered by binding of the postsynaptic partner to axonal RPTPs). The third 
is to trigger postsynaptic differentiation, local recruitment of neurotransmitter receptors, scaffolds, 
and signaling proteins (a form of anterograde synaptogenic signaling triggered by binding of the 
presynaptic RPTP to dendritic binding partners) (Takahashi and Craig, ; Um and Ko). 
In situ hybridization of mice brain samples revealed that PTPδ mRNA is present in the 
hippocampus, thalamic reticular nucleus, and piriform cortex, where some Src family PTKs have 
been also demonstrated to exist (Mizuno et al., 1993). In adult mice brain, PTPσ and PTPδ show 
substantial levels of expression, whereas LAR staining is hardly detectable above background 
levels. A distinct higher expression of PTPδ is apparent in the hippocampal CA2, CA3 region and 
in dentate gyrus (Kwon et al., ; Schaapveld et al., 1998; Uetani et al., 2000). In the cerebellum, all 
three transcripts are present in the granular cell layer. In the olfactory bulb, low levels of LAR 
expression are observed in the internal granular layer and the mitral cell layer. In contrast, high 
levels of PTPσ transcripts are not only present in these layers but also in the glomerular cell layer. 
Strikingly, PTPδ is restricted to the mitral and glomerular cell layers only (Schaapveld et al., 1998). 
PTPδ is also expressed in B lymphocytes and thymic medulla (Uetani et al., 2000).  
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Structurally, LAR-RPTPs undergo constitutive proteolytic processing, that generate an extracellular 
subunit that remains non-covalently bound to the transmembrane region of the phosphatase domain 
subunit (Takahashi and Craig, ; Wang and Bixby, 1999). 
This proteolytic cleavage takes place at a site in the ECD located near the membrane (Pulido et al., 
1995) and the protein is expressed on the cell surface as a complex of two noncovalently associated 
subunits of,140 and 85 kDa (Wang and Bixby, 1999) .  
Rabbit polyclonal antibody D5013 (Dunah et al., 2005) against the phosphatase domain D1 of 
human LAR-a domain that is highly conserved among LAR-RPTPs (all the three members of the 
LAR subfamily) was used on immunoblots of COS-7 cells transfected with LAR, PTPδ and PTPσ. 
D5013 antibody reacted with multiple species, including a top band of ~220–230 kDa that 
presumably corresponds to the full-length protein (LAR, 220 kDa; PTPδ, 220 kDa; and PTPσ 230 
kDa) and multiple smaller bands that probably arise from proteolysis of LAR-RPTPs, as no signal 
was observed in untransfected COS-7 cells (Dunah et al., 2005). In rat cerebral cortex, the LAR 
antibody recognized a major band of Mr ~85 kDa, which is likely to represent the P-subunit 
containing the transmembrane and intracellular regions of LAR, PTPδ and/or PTPσ. The ~220 kDa 
LAR polypeptide shifted to a lower molecular weight upon treatment with glycosidase, supporting 
the idea that it represents the full-length protein. The ~85 kDa band was unaffected, consistent with 
it being the P-subunit of LAR-RPTP(Dunah et al., 2005).  
Immunoblotting showed that LAR-RPTP proteins were widely expressed in different regions of the 
rat CNS, and at higher levels in postnatal day 7 (P7) brain than in adult (P45) brain, consistent with 
mRNA expression data. The ~85 kDa LAR-RPTP band showed the biochemical fractionation 
pattern expected for an integral membrane protein. LAR-RPTP was enriched in postsynaptic 
density (PSD) fractions, though to a lesser extent than PSD-95. At 7 d in vitro (DIV7), LAR-RPTP 
showed a fine punctate immunostaining in cell bodies and dendrites of cultured hippocampal 
neurons and only partial colocalization with PSD-95 or with bassoon, a protein expressed in the 
presynaptic active zone. With neuronal maturation, an increasing fraction of LAR puncta became 
synaptically localized, and an increasing percentage of synapses showed detectable LAR staining. 
The immunocytochemical data and biochemical findings are consistent with LAR-RPTP being 
enriched at excitatory synapses but more widely distributed in neurons than PSD-95 (Dunah et al., 
2005). 
Neurons expressing any single LAR-RPTP RNAi, or any combination of them, showed a lower 
density of spines and PSD-95 puncta than did vector-transfected cells. The LAR-RPTP RNAi–
transfected neurons also showed a substantial decrease in the surface staining intensity of AMPA 
receptor subunit GluR2 (Dunah et al., 2005).  
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Moreover, it was found that PTPδ-deficient mice were semi-lethal due to insufficient food intake. 
They also exhibited learning impairment in the Morris water maze, reinforced T-maze and radial 
arm maze tasks. Interestingly, although the histology of the hippocampus appeared normal, the 
magnitudes of long-term potentiation (LTP) induced at hippocampal CA1 and CA3 synapses were 
significantly enhanced in PTPδ-deficient mice, with augmented paired-pulse facilitation in the CA1 
region. Thus, it was shown that PTPδ plays important roles in regulating hippocampal LTP and 
learning processes, and that hippocampal LTP does not necessarily positively correlate with spatial 
learning ability (Uetani et al., 2000).  
RPTPs modulate their effects on cells also interacting with proteoglycans. Heparan and chondroitin 
sulfate proteoglycans (HSPGs and CSPGs, respectively) regulate numerous cell surface signaling 
events, with typically opposite effects on cell function (Coles et al., ; Milev et al., 1994; Garwood et 
al., 2003). 
Phosphacan is a CSPGs produced by glial cells in the central nervous system, and represents the 
extracellular domain of a receptor-type protein tyrosine phosphatase (RPTP zeta/beta). Binding to 
neural cell adhesion molecules, and possibly also by competing for ligands of the transmembrane 
phosphatase, phosphacan may play a major role in modulating neuronal and glial adhesion, neurite 
growth, and signal transduction during the development of the central nervous system (Milev et al., 
1994). Moreover, CSPGs inhibit nerve regeneration through RPTPσ: RPTPσ acts bimodally in 
sensory neuron extension, mediating CSPG inhibition and HSPG growth promotion. In summary, 
proteoglycans can exert opposing effects on neuronal extension by competing to control the 
oligomerization of a common receptor (Coles et al.). 
 
All the members of LAR-RPTPs family have a specific partner, different for each one, according to 
the possibility of selecting a molecular partner by insertion or exclusion of mini exons (me), short 
peptide of 4-16 aa. There are four mini exons, called meA, B, C and D (Yoshida et al., ; Pulido et 
al., 1995). meA and meB peptides are particular important by their localization into Ig domains: 
meA is predicted to affect the length of a loop region between the D and E β-strands of the second 
Ig-like domain, meanwhile the meB is predicted to affect the spacing between the second and third 
Ig-like domains. This feature is crucial to regulate the binding-affinity (Yoshida et al., ; Pulido et 
al., 1995).  
The postsynaptic binding partners of LAR-RPTPs in trans-synaptic complexes have been identified 
as follows: netrin-G ligand-3 (NGL-3), neurotrophin receptor tropomyosin-related kinase C (TrkC), 
IL1RAPL1, interleukin-1 receptor accessory protein (IL1RAcP), and Slit and NTRK-like family 
(Slitrk 1–6). NGL-3 binds to LAR, PTPσ, and PTPδ through their first two FNIII domains (in 
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vitro). TrkC binds selectively to PTPσ, IL1RAPL1 selectively to PTPδ, IL1RAcP to LAR, PTPσ, 
and PTPδ, and Slitrks selectively to PTPδ (in vitro)  and PTPσ, through the Ig domains of the 
RPTPs (Takahashi and Craig) (Fig. i). 
Comparison between members of IL-1/Toll receptor family involved in synapse maturation (i.e. 
IL1RAPL1 and IL1RAcP) and binding RPTPs underlines their specific localization: IL1RAPL1 
induces only excitatory presynaptic differentiation whereas IL1RAcP induces not only excitatory 
but also some inhibitory presynaptic differentiation. These differences suggest the possibility that 
glutamatergic and GABAergic axons may have differential expression patterns of RPTP family 
members and splice forms (Takahashi and Craig). 
Postsynaptic IL1RAcP and presynaptic PTPδ also function as a bidirectional excitatory synaptic 
organizing complex. IL1RAcP functions as a coreceptor with interleukin-1 receptor type I (IL1RI) 
for mediating immune and inflammatory responses to IL1 family cytokines, unlike IL1RAPL1 
which lacks such function. IL1RAcP appears to serve two distinct functions, one with IL1 and 
IL1R1 in immune regulation and inflammation and another with PTPδ in synaptic adhesion and 
synapse organization (Takahashi and Craig, ; Yoshida et al.).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. i. The selective binding code of receptor-type protein tyrosine phosphatases (RPTPs) with diverse postsynaptic 
partners: individual RPTPs bind to overlapping sets of postsynaptic partners, as indicated by the lines; broken lines 
indicate interactions that can occur in vitro but appear to lack physiological relevance. Importantly, except for netrin-G 
ligand-3 (NGL-3), these interactions are regulated by alternative splicing of RPTPs at the meA and meB sites 
(Takahashi and Craig). 
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The Slitrk family consists of six brain-specific transmembrane proteins (Slitrk 1–6) that are able to 
induce presynaptic differentiation. Intriguingly, Slitrk3 can induce inhibitory, but not excitatory, 
presynaptic differentiation. All Slitrks can interact with PTPδ (Takahashi et al.). RNAi-mediated 
knockdown of selective RPTPs in neurons co-cultured with Slitrk-expressing cells suggests that 
PTPs mediates the excitatory presynaptic differentiation induced by Slitrks, particularly Slitrk1 and 
Slitrk2 (Takahashi et al.). It is puzzling how Slitrk3–PTPδ can function selectively in inhibitory 
synaptic organization and IL1RAPL1/IL1RacP–PTPδ in excitatory synaptic organization. The 
PTPδ isoform that contains full meA and meB inserts, a major isoform of PTPδ in the brain, can 
bind to all Slitrks, IL1RAPL1, and IL1RacP, although perhaps with different affinity. Given that the 
meA and meB splice inserts of PTPδ differentially control its binding to IL1RAPL1 and IL1RAcP, 
it is possible that differential splicing of PTPδ in GABAergic versus glutamatergic axons 
contributes to selectivity in partner binding and function. Such a mechanism would be similar to the 
role of splicing in neurexins binding to different neuroligins. However, more complicated 
mechanisms involving axon-selective co-receptors or suppressors to regulate specificity of 
interactions cannot be ruled out. Whereas most of the other RPTP complexes have demonstrated 
bidirectional synaptic organizing activities, the Slitrk–PTPd/PTPs interaction has only been shown 
to induce presynaptic differentiation. A PTPd isoform that contains full meA and meB inserts and 
can bind to all Slitrks induces only excitatory not inhibitory postsyn-aptic protein clustering in co-
culture assays, suggesting that Slitrk3 may need to cooperate with other synaptogenic complexes 
such as neurexin–neuroligin-2 for inhibitory synapse development (Takahashi and Craig).  
 
Intracellularly, PTPδ interacts with MIM-B, a putative metastasis suppressor protein that is 
implicated in actin cytoskeletal control (Woodings et al., 2003). MIM was originally described as a 
protein whose mRNA was Missing in Metastasis. A variant of MIM, called MIM-B, was further 
characterized as a link between tyrosine kinase signalling and the actin cytoskeleton. MIM-B binds 
to the cytoplasmic domain of receptor PTPδ and the expression of full-length MIM-B induces actin-
rich protrusions resembling microspikes and lamellipodia at the plasma membrane and promotes 
disassembly of actin stress fibres. The C-terminal portion of MIM-B is localized in the cytoplasm 
and does not affect the actin cytoskeleton when expressed, while the N-terminal portion localizes to 
internal vesicles and probably targets the protein to membranes. MIM-B may be a regulator of actin 
assembly downstream of tyrosine kinase signaling and this activity may explain the involvement of 
MIM in the metastasis of cancer cells (Woodings et al., 2003). 
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The interaction between IL1RAPL1 and PTPδ has been confirmed by a HEK293FT co-culture 
using IL1RAPL1 or IL1RAPL1∆N (a deleted form of the protein, lacking the first and the second 
Ig-like domain) (Valnegri et al.). Only the full length form of IL1RAPL1 can enhance accumulation 
at sites of contact with PTPδ-transfected cells. The same experiment was performed with other 
members of LAR-RPTPs (LAR and PTPσ) and it excluded any interaction of these proteins with 
IL1RAPL1 (Valnegri et al.).  Similarly, IL1RAPL2 specifically interacts with PTPδ but not with the 
other members of the LAR-RPTP family. Data have been confirmed by immunoprecipitation 
experiments (Valnegri et al.).  
However, it has not been definitively shown whether dendritic recruitment of IL1RAPL1 by PTPδ 
is sufficient to recruit postsynaptic proteins, for example, by direct aggregation of IL1RAPL1 on 
dendrites this probability is supported by the finding that soluble IL1RAPL1 ectodomain inhibits 
postsynaptic differentiation by PTPδ (Yoshida et al.). 
All these findings suggest that the IL1RAPL1complex, similarly to the neuroligin/neurexin 
complex, regulates trans-synaptic signaling that induces excitatory synapse and dendritic spine 
formation in brain.  
 
Recently it has been discovered by affinity chromatography a new partner of IL1RAPL1: Mcf2-like 
(Mcf2l), a Rho guanine nucleotide exchange factor (GEF) that activates RhoA and Cdc42 and binds 
to TIR domain of IL1RAPL1. RhoA and Rac1 are implicated in the cytoskeletal dynamics that 
induce structural change of excitatory spines. Actin cytoskeletal dynamics are regulated by RhoA-
dependent activation of ROCK (Rho-associated protein kinase) (Hayashi et al.).  
Knockdown of endogenous Mcf2l and treatment with an inhibitor of ROCK suppressed 
IL1RAPL1-induced excitatory synapse formation of cortical neurons, suggesting that IL1RAPL1 
controls spine formation of cortical neurons through Mcf2l-RhoA-ROCK signaling pathway. 
Because the suppression is not total it can be supposed that other pathway(s) besides Mcf2l-RhoA-
ROCK one may support the endogenous IL1RAPL1-mediated spinogenesis when Mcf2l-RhoA-
ROCK pathway in cortical neurons is blocked  (Hayashi et al.). 
Furthermore, it was found that the expression of IL1RAPL1 affected the turnover of AMPA 
receptor subunits and Mcf2l-RhoA-ROCK signaling pathway acts in the downstream of IL1RAPL1 
in excitatory synapse stabilization (Hayashi et al., 2013). One process that is important in 
maintaining synaptic strength unchanged and in stabilization of recently formed synapses is the 
constitutive replacement of synaptic GluA1 by GluA2/3 (AMPAR subunits) (Granger et al.). This 
process takes up to 20 hr. The over-expression of IL1RAPL1 for 2 to 3 days in cortical neurons 
leads to the replacement of newly inserted AMPA receptor compositions through the Mcf2l-RhoA-
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ROCK signaling pathway. In summary, IL1RAPL1, through Mcf2l-RhoA-ROCK signaling 
pathway, regulates the formation and stabilization of glutamatergic synapses between cortical 
neurons (Hayashi et al.). 
  
All this data strongly suggests that most of the molecules found associated with ID regulate synapse 
formation and the consequential functional alteration or reduction in number of excitatory or 
inhibitory synapses arising from their mutations may alter the balance between excitatory and 
inhibitory synapses. This induces a general disorder within neuronal circuits and may be the direct 
cause of ID and ASD in humans. Indeed, even small changes in the expression and function of these 
proteins can provoke major alterations in synaptic connectivity, resulting in cognitive damages. 
The learning deficiencies and memory declines observed in IL1RAPL1 knockout mice mimic the 
symptoms of ID children with IL1RAPL1 mutations (Yasumura et al.). ID children with deletions in 
the IL1RAPL1 gene have slow developmental milestones such as the onsets of walking and speech 
and require special education (Barone et al., ; Behnecke et al., ; Franek et al., ; Nawara et al., 2008). 
The IL1RAPL1 gene is also associated with ASDs (Youngs et al., ; Bhat et al., 2008; Piton et al., 
2008). ASDs are characterized by impairments in appropriate reciprocal social interactions, 
impairments in verbal social communication and high levels of ritualistic repetitive behaviours 
(Crawley, 2004). IL1RAPL1 knockout mice show a stereotyped behavior (Yasumura et al.) and 
their  behavioural flexibility is slightly reduced in the reversal task of the T-maze left-right 
discrimination test but not in that of the Barnes maze test (Yasumura et al.). Interestingly, the 
performance of IL1RAPL1 knockout mice in the rotarod test is significantly better than that of 
wild-type mice (Yasumura et al.), which may be interpreted that IL1RAPL1 knockout mice prone 
to be stereotypic in behaviour since better performance in repetitive test of motor coordination was 
also reported for mutant mice exhibiting autistic behaviour (Kwon et al., 2006; Nakatani et al., 
2009). However, the social interaction of IL1RAPL1 knockout mice results increased in one-
chamber and Crawley’s three-chamber social interaction tests (Yasumura et al.). In addition, vocal  
communications of IL1RAPL1 knockout mice are comparable to those of wild-type mice 
(Yasumura et al.). 
Another characteristic feature of IL1RAPL1 knockout mice is an enhanced locomotor activity 
(Yasumura et al.), thus, hyperactive behaviour reported for ID patients with mutations in the 
IL1RAPL1 gene (Barone et al., ; Behnecke et al., ; Franek et al., ; Nawara et al., 2008) is reproduced 
in IL1RAPL1 knockout mice (Yasumura et al.). In the social interaction test, hyperactivity may 
increase the number of contacts in IL1RAPL1 knockout mice, while the mean duration per contact 
was comparable between genotypes (Yasumura et al.). It is unlikely that locomotor activity would 
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strongly affect the indices employed in spatial and working memory tests (Yasumura et al.). 
Moreover IL1RAPL1 knockout mice show a the deficits in fear memories (Houbaert et al., ; 
Yasumura et al., ; Zhang et al.) and an anxiety reduction (Yasumura et al.).  
Present studies with mutant mice revealed that the ablation of IL1RAPL1 affects diverse brain 
functions including learning, memory, behavioural flexibility, locomotor activity and anxiety 
(Pavlowsky et al., ; Yasumura et al., ; Zhang et al.).  
Decrease of spine density in IL1RAPL1 mutant mice will cause excitation and inhibition 
imbalances in many brain circuits, since IL1RAPL1 is widely expressed in the brain (Houbaert et 
al., ; Zhang et al., ; Carrie et al., 1999). Thus, it is reasonable that multiple brain functions are 
affected by the mutation (Yasumura et al.).  
For instance, the altered I/E balance at the hippocampo-BLA projections leads to a deficit in 
contextual memory expression rather than memory formation, thereby  suggesting that cognitive 
disability in humans may result from the deficiency of synapses involved at different steps of the 
cognitive process, including memory restitution and behavioral expression. (Zhang et al.) 
Human patients with IL1RAPL1 mutations are classified as ID and/or ASDs (Behnecke et al., ; 
Franek et al., ; Youngs et al., ; Carrie et al., 1999; Tabolacci et al., 2006; Bhat et al., 2008; Nawara 
et al., 2008; Piton et al., 2008). It remains to be examined how neural circuits responsible for these 
mental disorders are mainly affected by IL1RAPL1 mutations (Yasumura et al.).  
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MUTATIONS OF IL1RAPL1 
Different mutations in IL1RAPL1 gene have been discovered in members of families with 
intellectual disability and autism.  
First, Carriè et al. identified a patient with a C-A transition in exon 11 that changes the codon 
codifing tyrosine (TAC) in a stop codon (TAA) (Y459X): it results in a protein lacking a part of the 
TIR domain and all the C-terminal domain (Carrie et al., 1999).  
In another family, three male with ID and IQ<70 have a truncated form of protein that lacks the last 
210 aminoacids in the cytoplasmic domain, because of a transition G1460A in exon 10 of gene 
resulting in a substitution trp487stop (W487X) (Tabolacci et al., 2006). Moreover in three brothers 
with IG 55, hyperactivity, attention deficit, auto-aggressivity, dysmorphism, has been discovered a 
truncated form of IL1RAPL1 due to a deletion in exon 11 (Youngs et al.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. l. Patients with mutations or deletions in IL1RAPL1 gene show some facial features like strabism, ptosis, high nasal 
bridge and broad nasal base, large mouth and macrodontia of the central maxillary incisors, etc. 
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Another mutation (seven nucleotide deletion c.1730delTACTCTT) in exon 9 cause a frameshift at 
Ile367 with a premature stop codon (TGA) 6 codons downstream (p.Ile367SerfsX6) resulting in a 
truncated protein that lacks a part of the transmembrane domain as well as the entire cytoplasmic 
domain: the protein can't reach the cell surface (Piton et al., 2008). In another family, a frameshift 
mutation (A28EfsX15) results in the exclusion of exons 3, 4, 5, 6 and 7 (Piton et al., 2008). Last 
two mutations described are involved both in ID and ASD (Piton et al., 2008). An other deletion in 
the extracellular domain (exons 2, 3, 4, 5 and 6 of the gene) was described by Nawara et al., 2008 
and Franek at al., 2011 (Franek et al., ; Nawara et al., 2008). Patients present hyperactivity ID, 
aggressivity (Nawara et al., 2008), low IQ and dysmorphism (Franek et al.).   
The same research group discovered in two male brothers a deletion in exons 1–5; in this case 
IL1RAPL1 protein is absent in patients and, interestingly, they don't correlate with ASD (Franek et 
al.). Deletions of exons coding for the extracellular regions has been found in two German patients 
with low IQ that belong to two different-non related families and share psychomotor development 
delay: one has exon 2 deleted, in the other one the deletion starts 245454 bp after exon 2 and ends 
117424 bp after exon 5 (Behnecke et al.). An Italian patient with ID, ASD and an epilepsy episode 
presents a 285 Kb deletion in chromosome Xp21.3-21.2, with breakpoints lying in IL1RAPL1 gene 
exon 3 (Barone et al.). 
It has also been identified an inversion in chromosome X, inv(X)(p21.3q27.1) (Lepretre et al., 
2003) and a complex deletion-inversion that drives to a loss of different gene and to a creation of a 
fusion protein between IL1RAPL1 and distrofin (Wheway et al., 2003). 
Interestingly also a duplication can lead to pathology: a 15.5-Mb duplication (Xp11.4-p21.3 region 
containing 41 genes including IDX IL1RAPL1 and TSPAN7) can leads to ID, suggesting the 
importance of regular dosage of protein (Froyen et al., 2007). 
During my phD in Carlo Sala laboratory, we decided to study the function of three novel 
independent mutations on IL1RAPL1 in patients presenting mild to moderate ID: 
IL1RAPL1∆exon6 (Ramos-Brossier et al.), IL1RAPL1 C31R (Ramos-Brossier et al., ; Tarpey et 
al., 2009) and IL1RAPL1 I643V (Ramos-Brossier et al., ; Piton et al., 2008). Two of them affecting 
the same exon, and unlike most of previously reported mutations, those are predicted to lead to 
protein synthesis but to damage extracellular domain. The identification of these novel mutations on 
IL1RAPL1 and the clinical characterization of the patients is reported in (Ramos-Brossier et al.).   
Most of the mutations and deletions involving IL1RAPL1 gene are summarized in table m. 
The majority of the described mutations include large deletions, and it is of particular interest that 
they mostly involve the first exons coding for extracellular domain of IL1RAPL1 protein. Some 
authors suggest that because of the incidence of genomic rearrangements, such as pericentromeric 
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inversions, this region must be particularly prone to recombination (Franek et al., ; Lepretre et al., 
2003; Nawara et al., 2008).  
In summary, most of mutations described above leads to the absence of IL1RAPL1 production or to 
a small or truncated form of the protein: this can result in the loss of some protein-protein 
interactions due to the lack of interacting regions. Alternatively, other mutations result in a 
completely loss of the protein or loss of the correct localization (Barone et al., ; Behnecke et al., ; 
Franek et al., ; Koh et al., ; Youngs et al., ; Carrie et al., 1999; Bahi et al., 2003; Lepretre et al., 
2003; Wheway et al., 2003; Tabolacci et al., 2006; Froyen et al., 2007; Nawara et al., 2008; Piton et 
al., 2008). 
Interestingly, mutations and deletion of IL1RAPL1 gene are related to different phenotypes (even in 
the same family and in patients with the same mutation) including different severity of ID, 
association or not with ASD and other physical features. Moreover, the phenotype of carrier female 
is interesting: even if most of the carrier females have normal cognitive skills, there are some cases 
of mild cognitive impairments or learning difficulties, maybe due to a different X-inactivation 
pattern  (Tabolacci et al., 2006). 
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Table m. Reported mutations on IL1RAPL1 gene in ID patients, and their consequences for protein function. 
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AIM OF THE WORK 
Interleukin-1 receptor accessory protein like 1 (IL1RAPL1) gene is localized on X chromosome and 
mutations/deltions of this gene are strongly associated to ID and autism spectrum disorder (ASD) 
(Carrie et al., 1999; Piton et al., 2008). IL1RAPL1 is localized at the postsynaptic compartment of 
excitatory synapses (Pavlowsky et al.) and plays an important role in synapse formation and 
stabilization in developmental brain (Pavlowsky et al., ; Valnegri et al.).  
Several studies indicate that ID is associated with abnormalities of dendrites and dendritic spines, 
resulting in a defect in neuronal connectivity and thus an altered processing of information at both 
the cellular and the neural network. Thus, functional analysis of IL1RAPL1 might be of interest to 
identify the molecular or cellular mechanisms that contribute to cognitive functions. 
Even if IL1RAPL1 function has been already described (Hayashi et al., ; Houbaert et al., ; 
Pavlowsky et al., ; Valnegri et al., ; Yasumura et al., ; Yoshida et al., ; Gambino et al., 2007; 
Yoshida and Mishina, 2008; Gambino et al., 2009), there is an incomplete view of which effects of 
the mutations or the absence of the protein have on synapses, neurons, and neural networks. 
Accordingly, the aim of presented work was to characterize IL1RAPL1 mutants identified in 
patients with intellectual disability and autism (this part of the data has already been published 
(Ramos-Brossier et al.), thus the results and their discussion are not fully reported in this Thesis) 
and to perform a behavioural and neuronal morphology analysis on IL1RAPL1 KO mice. In 
particular, we decided to study the function of three novel independent mutations on IL1RAPL1 in 
patients presenting mild to moderate ID: IL1RAPL1∆exon6, IL1RAPL1 C31R and IL1RAPL1 
I643V (Ramos-Brossier et al.). Two of them affecting the same exon, and unlike most of previously 
reported mutations, those are predicted to allow protein synthesis of a mutated protein with a 
damaged extracellular domain (Ramos-Brossier et al.). 
In particular, through over-expression of the IL1RAPL1 mutants in rat primary cultured neurons, 
we studied their localization, the ability to recruit presynaptic compartment and to induce changes 
in neuronal morphology and spine density. To better understand the molecular interaction between 
IL1RAPL1 and PTPδ, we also investigate, through a cell aggregation assay, the residual ability of 
IL1RAPL1 mutants to bind PTPδ (Ramos-Brossier et al.). Moreover, given that dendritic 
abnormalities are one of the most consistent anatomical correlates of ID, we also characterize the 
role of wild type and mutants IL1RAPL1 in regulating dendrite morphology using both in vitro 
neuronal culture and IL1RAPL1 KO mice.  
Furthermore, IL1RAPL1 WT and KO mice have been analyzed with behavioural test to point out 
differences in motor activity, memory and anxiety.    
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Understanding how mutations or absence of IL1RAPL1 act on synaptogenesis and dendritic 
morphology can help to clarify how any changes in IL1RAPL1 function can lead to cognitive 
disorders in humans.  
In addition, further investigation of the molecular mechanism of IL1RAPL1 would identify 
potential drug targets and IL1RAPL1 knockout mice will be useful to assess the new possible 
treatments. 
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MATERIALS AND METHODS 
 
cDNA CONSTRUCTS 
HA-tagged human IL1RAPL1 described before (Pavlowsky et al.) was modified using QuikChange 
II XL Site-Directed Mutagenesis Kit (Agilent Technologies) to generate ∆ex6, C31R, I643V and 
∆Ig123 constructs (Ramos-Brossier et al.). Myctagged PTPδ, IL1RAPL1 ∆C, IL1RAPL1 ∆N, 
IL1RAPL1 ∆8 were described elsewhere (Pavlowsky et al., ; Valnegri et al.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Human PTPδ full length is a gift from E. Kim (Kwon et al.). Rat PTPδ without miniexons A and B 
is a gift from M. Mishina (Yoshida et al.). shRNA plasmid against rat PTPδ is a gift from Ann 
Marie Craig.  
All this transmembran proteins cDNA is inserted in GW1-CMV vector. The signal peptide of 
IL1RAPL1 (aa 1-25) and PTPδ was switched with signal peptide of GluR2 (AMPA receptor 
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subunit), a not cleavable signal peptide to ensure a cytoplasmic membrane localization and, 
downstream, HA tag was inserted.  As control, pEGFP vector was also used. 
 
ANTIBODIES 
The following primary antibodies were used: rabbit anti-IL1RAPL1 (K10, (Pavlowsky et al.)), goat 
anti-IL1RAPL1 (R&D), rabbit anti-IL1RAPL1 (Proteintech), mouse anti-GFP (Roche and Abcam), 
rabbit anti-VGLUT1 (Synaptic Systems), rabbit anti-VGAT (Synaptic Systems), rabbit anti-HA-tag 
(Santa Cruz Biotechnology), mouse anti-HA-tag (Roche), mouse anti-c-Myc (Santa Cruz 
Biotechnology), mouse anti-PSD-95 (Affinity Bioreagents), rabbit anti-synaptophysin (Cell 
Signaling and Sigma Aldrich), mouse anti-GAPDH (Ambion), mouse anti-LAR (Neuromab), rabbit 
anti-PTPδ (Santa Cruz Biotechnology), goat anti-ARHGAP22/RhoGAP2 (Santa Cruz 
Biotechnology), rabbit anti-mGluR5 (Millipore), mouse anti-mGluR1/5 (Neuromab), rabbit anti-
GluR1 (Millipore), mouse anti-GluR2 (Neuromab), mouse anti-GluR2/3 (gift from Cecilia Gotti), 
mouse anti-NR1 (Neuromab), mouse anti-NR2B (Neuromab), rabbit anti-ERK 1/2 (Cell Signaling), 
mouse anti-panShank (Neuromab), rabbit anti-Shank3 (Santa Cruz Biotechnology), mouse anti-
Homer (Santa Cruz Biotechnology), mouse anti-PSD-95 (Neuromab), mouse anti-Neuroligin 1 (gift 
from Nils Brose), mouse anti-βActin (Sigma Aldrich), mouse anti-GAD-65 (Abcam). 
All HRP-conjugated secondary antibodies were purchased from Jackson ImmunoResearch Labs. 
All fluorophore-conjugated secondary antibodies were purchased from Jackson ImmunoResearch 
Labs. 
 
CELL CULTURE AND TRANSFECTION OF PRIMARY RAT AND MOUSE HIPPOCAMPAL 
NEURONS 
Low-density rat hippocampal neuronal cultures were prepared from embryonic day (E) 18-19 
hippocampi as previously described with minor modifications (Verpelli et al., ; Sala et al., 2001) 
and were grown in 12-well Petri dishes (Primo). 
Neurons were transfected using Lipofectamine 2000 on Days In Vitro 11 (DIV11) and experiments 
were performed at DIV14-18. Experimental procedures on animals were approved by the local 
ethical committee. At DIV1 Neuronal primary cultures were transfected with calcium chloride 
method as described previously (Verpelli et al.) and experiments were performed at DIV4.  
 
IMMUNOCYTOCHEMISTRY  
Cells were fixed in 4% PFA plus 4% sucrose at room temperature for 20 minutes, or 100% 
methanol at -20° for 10 min. Primary (1:100-1:800) and secondary (1:200) antibodies were applied 
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in GDB buffer (30 mM phosphate buffer, pH 7.4, 0.2% gelatin, 0.5% Triton X-100, 0.8 M NaCl (all 
Sigma-Aldrich)) or in PBS (136.8 mM NaCl, 2.68 mM KCl, 10.1 mM Na2HPO4 and 1.76 mM 
KH2PO4 , pH 7.4 (all Sigma-Aldrich)) containing 3% BSA and 0.2% Tween 20. Primary antibodies 
were applied for 1-3 h at room temperature. Secondary antibodies conjugate with fluorophores 
(Jackson Immunoreserch) were also diluted in GDB buffer and applied for 1 h. After each antibody 
incubation, 3 washes (10 min each) took place with “high-salt buffer” (20mM Na2HPO4/NaH2PO4 
and 0.5M NaCl, pH 7.4 (all Sigma-Aldrich)) and before mounting a final wash (for 10 min) was 
carried out with PBS. Before mounting, coverslips were briefly passed through ddH2O to dilute 
salts. 4',6-diamidino-2-phenylindole (DAPI) staining (Life Technologies) was carried out for 2 min 
(DAPI diluted in PBS to a final concentration of 0.5 µg/ml) and took place during the washing steps 
before mounting the coverslips with Mounting Medium (Vecta Shield). 
 
NEURON SURFACE STAINING 
At DIV 14-15, live hippocampal neurons were labeled for 10 min at 37°C with anti-HA-tag rabbit 
antibody (10 µg/ml). After washing, neurons were fixed with paraformaldehyde (PFA) 4% plus 4% 
sucrose and incubated with anti-HA-tag mouse antibody in GDB (30 mM phosphate buffer, pH 7.4, 
0.2% gelatin, 0.5% Triton X-100, 0.8 M NaCl (all Sigma-Aldrich)) for 3 h at room temperature. 
Cells were washed in 20 mM phosphate buffer containing 0.5 M NaCl and incubated with FITC- 
and Cy3-conjugated secondary antibodies. 
 
IMAGE ACQUISITION AND PROCESSING 
Confocal images were obtained using a Zeiss 510 confocal microscope (Carl Zeiss, a gift from 
Fondazione Monzino) or a Leica DMI6000 Spinning disk microscope (PerkinElmer, a gift from 
Fondazione Monzino) with Zeiss 63 x, 40x or 20x objectives at a resolution of 1024 x 1024 pixels. 
Images represent maximum intensity projections of five individual images taken at depth intervals 
of around 0.5 µm. 
Quantification of synaptic protein staining was performed using MetaMorph (Molecular Devices, 
Downingtown, PA), and ImageJ software and NeuronJ plugin (Meijering et al., 2004). Labeled, 
transfected cells were chosen randomly for quantification from six coverslips from 3 independent 
experiments for each condition and image analysis was performed under blind condition. 
Quantification of protein surface staining was performed using MetaMorph (Molecular Devices, 
Downingtown, PA), and ImageJ software. The ratio of integrated intensity of surface rabbit anti-HA 
signal per total mouse anti-HA signal was measured for each neuron. Then we calculated the mean 
and SEM for the neurons transfected with the same construct. 
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Sholl analysis was performed using NeuronStudio (Computational Neurobiology and Imaging 
Center Mountain Sinai School of Medicine, New York, NY). Sholl analysis is a method of 
quantitative analysis used in neuronal studies to characterize the morphological features of an 
imaged neuron. It creates a series of concentric circles around the soma of the neuron. Within each 
sphere various metrics can be obtained such as the total length of intersecting dendrites or the 
number of branching points. We performed Sholl analysis to measure the number of branching 
points in order to evaluate the dendritic arborization complexity in adult neurons (DIV14-15). 
Young neurons (at DIV4) were analyzed manually: the number of primary and secondary dendrites 
was counted together with the total length of counted dendrites using MetaMorph softwere. 
 
DATA ANALYSIS AND FIGURE DISPLAY 
Data was analyzed for statistical significance and displayed by Prism 5 software (GraphPad, San 
Diego, CA). If there were only two groups whose means were compared, a student’s t-test was 
carried out to assess statistical significance. The accepted level of significance was p ≤ 0.05. To 
compare more than two groups, one factorial analysis of variance (ANOVA) was used and if group 
means differed in a significant manner (p ≤ 0.05), a post hoc Dunnet (groups compared to the 
control) and Tukey (all groups compared) test was calculated to assess statistical significance. The 
accepted level of significance for the post hoc test was p ≤ 0.05. 
In graph, data are presented as mean ± SEM. 
 
 
CULTURED NEURONS OR BRAIN LYSATES IMMUNOBLOT ANALYSIS 
Cultured neurons or brain lysates were collected with precooled “sucrose buffer” (0.32 M sucrose 
(Sigma-Aldrich)/4mM HEPES-NaOH buffer (Sigma-Aldrich), pH 7.3, protease inhibitors (Roche), 
phosphatase inhibitors (Roche)) and analyzed via Bradford protein assay (Bio-Rad) to asses protein 
concentration. For total lysate (TL), proteins were solubilized in 2-4x loading buffer/dye ((250 mM 
Tris, 8 % (w/v), 40 % (v/v) glycerol, 0.008 % (w/v) bromophenol blue (all Sigma-Aldrich)) in order 
to have a final protein concentration of 1 µg/µl in the sample. In other cases, fractionation took 
place prior to Bradford protein assay analysis resulting in a P1 fraction (enriched in cell bodies and 
dendritic fragments) and a P2 or crude synaptosomal fraction (enriched in presynaptic and 
postsynaptic components) (Grabrucker et al., ; Huttner et al., 1983). Also in the case of P1 and P2 
fractions, 2-4x loading buffer was added in order to have a final protein concentration of 1 µg/µl in 
the sample. 1mM DTT (DL-Dithiothreitol, Sigma-Aldrich) was added to the samples for reducing 
protein disulfide bonds. Samples were then heated for 10 min at 65°C (thermoblock from FALC 
Instruments) and 25 mM Iodoacetamide (Sigma-Aldrich), an alkylating reagent for cysteine 
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residues was added to eliminate artifacts of disulfide formation during electrophoresis. 10 µg of 
samples were loaded in the pockets of 6-15% polyacrylamide gels (home made with reagents from 
Bio-Rad) and proteins were electrophoretically seperated by sodium dodecyl sulfate-
Polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were electrophoretically seperated by 
SDS-PAGE under denaturing conditions (Laemmli, 1970) followed by electroblotting of the 
proteins onto a nitrocellulose membrane using the Trans-Blot Turbo System (Bio-Rad). Then the 
membranes were stained by Ponceau S Stain (Sigma-Aldrich) to control for efficient protein 
transfer of proteins and were subsequently washed twice in Tris-buffered saline-Tween (TBS-T) (20 
mM Tris pH 7.4, 150 mM NaCl (both Sigma-Aldrich), and 0.1% Tween 20 (Bio-Rad)). 
Blocking of membranes took place for at least 1.5 h at 4°C in blocking buffer (TBS-T and 5% dried 
nonfat milk). Primary antibodies were applied for 1-3 h in blocking buffer (here: with 3 instead of 
5% dried nonfat milk). For rat neuronal culture lysates, HRP-conjugated secondary antibodies 
(Jackson ImmunoResearch Laboratories) were used in blocking buffer (here: with 3 instead of 5% 
dried nonfat milk) and chemiluminescence was induced using an ECL kit (GE Healthcare).  
Normalization took place via actin for both TL and P2 samples.  
 
ANIMALS 
To prepare primary neuronal rat cultures, pregnant female rats (Rattus norvegicus) of the phylum 
Wistar were purchased from Charles River (Charles River Laboratories, Calco, Italy).  
IL1RAPL1-KO mice are derived via Cre-LoxP by substitution of exon 5 with a stop codon on a 
C57BL/6 background (Charles River Laboratories, Calco, Italy) as described before (Takagi et al., 
2002; Gambino et al., 2009). 
Mice and rats were housed under constant temperature (22 ± 1°C) and humidity (50%) conditions 
with a 12 h light/dark cycle, and were provided with food and water ad libitum. For proteomic 
analysis, Golgi staining and behavioral tests of IL1RAPL1-KO and WT mice, 3 months old 
littermates were used. 
All experiments involving animals followed protocols in accordance with the guidelines established 
by the European Communities Council and the Italian Ministry of Health (Rome, Italy). 
Experimental procedures of behavioral analysis followed the guidelines established by the Italian 
Council on Animal Care and were approved by the Italian Government decree No. 17/2013. All 
efforts were made to minimize the number of subjects used and their suffering. 
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GENOTYPING OF MICE 
For genotyping of mice, DNA was extracted from tails and analyzed by PCR with the REDExtract-
N-AmpTM Tissue PCR Kit (Sigma-Aldrich). 
 
GOLGI STAINING 
Mice were perfused transcardially with 0,9% NaCl in distilled water, the brain was taken and  
immersed in Golgi-Cox solution (1% K2Cr2O7, 1%HgCl2, 1% K2CrO4 (all Sigma-Aldrich)) (Glaser 
and Van der Loos, 1981) for 2-6 days in the dark, at room temperature. Golgi-Cox solution should 
be prepared at least five days before the impregnation, stored in the dark and filtered before use. 
After the period of impregnation, the brain was washed three times with distilled water, immersed 
in a 30% sucrose solution and stored at 4°C, in the dark, for at least one week. 
The brain was cutted with a vibratome setting frequency at 5.0, speed at 3.0 and slice thickening at 
80-100 µm; during the operation the sample was kept wet with a 6% sucrose solution. Slices were 
put on gelatinized slides (2% gelatin, 1% Kcr(SO4)12H2O). 
Slices was stained in the dark: first, slides were washed 2 times with distilled water for 5 minutes, 
then put 30 minutes in ammonium hydroxide (Sigma-Aldrich). After another step of distilled water 
washes, slides were put in Kodak solution (Sigma Aldrich) for 30 minutes. Slides were washed 2 
times in distilled water, and then 1 minute in each crescent percentage of ethanol (Fluka): 50%, 
70%, 95% and 2 times for 5 minutes in 100% ethanol. Finally slides were put for 15 minutes in 
solution X (1/3 chloroform (Sigma-Aldrich), 1/3 xylene (Carlo Erba), 1/3 ethanol) and then 15 
minutes in xylene. Slides were mounted on coverslips with Entellam (Electron Microscpy 
Sciences). Images were with 20x objective in white field. Neurons were analyzed with Neuron 
Studio software to perform a Sholl analysis of branching points. 
 
OLFACTORY TEST 
Two days before the test, an unfamiliar palatable food (Kellogg’s chocolate cereal) is placed 
overnight in the home cage of the subject mice. On the day of the test, each mouse is placed in a 
large cage containing 3 cm deep sawdust and allowed to explore for 5 minutes. The animal is 
removed from the cage and one cereal is buried in the cage bedding. The animal is then returned to 
the cage and given 15 minutes to locate the buried food. Latency to find the cereal is recorded. 
 
SPONTANEOUS MOTOR ACTIVITY 
Spontaneous motor activity was evaluated as previously described (Braida and Sala, 2000) in an 
automated activity cage (43×43×32 cm) (Ugo Basile, Varese, Italy), placed  in  a  sound-attenuating  
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room. The cage was fitted with two parallel horizontal and vertical infrared beams located 2.5 cm 
and 5 cm from the floor, respectively.  
Cumulative horizontal and vertical beam breaks were counted for 60 min. 
 
ELEVATED PLUS MAZE 
The Elevated Plus Maze paradigm was used to study anxiety related behavior. The apparatus  
consisted of two opposite open arms (30 cm x 10 cm) and two enclosed arms (30 cm x 10 cm x 14 
cm) that extended from a common central platform (10 cm x 10 cm) according to Lister (Lister, 
1987). The apparatus was built with white wood, elevated to a height of 60 cm above floor level 
and placed in the center of a small quiet room under dim light (about 30 lux). Testing was 
conducted during the early light phase (9.30–13.30 am) of the light cycle. After 20 min adaptation 
to the novel surroundings, mice were placed individually onto the center of the apparatus facing an 
open arm. The number of open- and closed-arm entries and the time spent in open and closed arms 
were recorded for 5 min. 
 
MORRIS WATER MAZE 
The water maze was a circular tank (diameter 1.5 m) filled with water (25°± 0.5°C). A platform 
(13.5 cm x 23 cm) was submerged below the water’s surface in the center of the target zone. 
Floating polystyrene particles were placed on the surface of the water to hide the platform from 
sight. Extra maze cues (simple geometrical shapes) and visual references (chair, table) were present 
around the room to provide spatially oriented cues. Intra-maze cues along the edge of the pool were 
also located. Four points around the circumference of the maze were arbitrarily designated as N, S, 
E, and W, which served as a reference for experimenters when releasing the mice into the pool. 
Within each acquisition session (i.e. 4 trials in a day), mice were randomly released from each of 
the four points, facing the pool wall. 
After one day of habituation in the maze for 60 s without the platform, acquisition training 
consisted of 4 trials per day for four consecutive days and an intertrial interval of 1 h. Once the 
mouse located the hidden platform, the mouse remained on the platform for 30 s before removal 
from the tank. If a mouse failed to locate the platform within 120 s, it was guided to the platform 
and remained there for 30 s before removal from the pool. The sixth day, the platform was removed 
(probe test) and the animals were allowed to remain in the pool for 120 s. An experimenter, blind to 
the genotype, manually recorded the escape latency and time spent in the target zone of the maze. 
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PASSIVE AVOIDANCE 
Briefly, the apparatus consisted of two compartments, one light and one dark, connected via a 
sliding door. In the acquisition trial, each mouse was placed in the light compartment and allowed 
to enter the dark compartment; the time (in s) taken to do so was recorded. Mice having latencies 
greater than 40 s were eliminated. Once the mouse was in the dark compartment, the sliding door 
was closed and an unavoid- able electric shock (1 mA for 1 s) delivered via the paws. 
The animal was then placed back in the home cage until the retention trial. The retention trial was 
carried out 30 min or 24 h after the acquisition trial, by positioning the mouse in the light 
compartment and recording the time taken to enter the dark compartment (retention latency). An 
increased retention latency indicates that the animal has learned the association between the shock 
and the dark compartment. During the retention trial, a cut-off time of 180 s was used. 
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RESULTS 
 
NOVEL IL1RAPL1 MUTATIONS ASSOCIATED WITH INTELLECTUAL DISABILITY 
IMPAIR SYNAPTOGENESIS 
We studied the function of three novel independent mutations of IL1RAPL1 gene in patients 
presenting mild to moderate ID (Ramos-Brossier et al.): IL1RAPL1∆exon6, IL1RAPL1 C31R and 
IL1RAPL1 I643V. Through over-expression of the IL1RAPL1 mutants in rat primary cultured 
neurons, we studied their localization, the ability to recruit presynaptic compartment and to induce 
changes in neuronal morphology and spine density. To better understand the molecular interaction 
between IL1RAPL1 and PTPδ, we also investigate, through a cell aggregation assay, the residual 
ability of IL1RAPL1 mutants to bind PTPδ (Ramos-Brossier et al.).  
We found that two of the studied mutants lead to a partial loss of function of IL1RAPL1 protein, 
which is, first, responsible for the cognitive impairments observed in patients and, second, 
highlights the important function of the extracellular domain for the trans-synaptic 
PTPδ/IL1RAPL1 interaction in synaptogenesis. 
This part of the data has already been published (Ramos-Brossier et al.), thus the results and their 
discussion are not fully reported in this Thesis. 
 
 
 
THE X-LINKED INTELLECTUAL DISABILITY PROTEIN IL1RAPL1 REGULATES 
DENDRITIC ARBORIZATION 
 
Dendritic arborization complexity of hippocampal neurons is altered in IL1RAPL1-KO adult 
mice 
Because genetic form of intellectual disability and autism are often associated to alteration in 
dendrites morphology, we decided to analyse dendritic arborisation complexity in wild type and 
IL1RAPL1 KO mice using Golgi staining of CA1 (Fig. 1), CA2 (Fig. 2) and Occipital and Parietal 
cortex neurons (Fig. 3) from 3 months old male littermates,. Sholl analysis was performed on 8 
neurons for each brain field for 4-9 animals of each genotype using Neurostudio softwere. Total 
number of branching points was counted (Fig. 1b, 2b, 3b) and plotted on the distance from the soma 
(Fig. 1c, 2c, 3c). 
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We observed an increased number of branching points in IL1RAPL1-KO mice hippocampal 
neurons of CA1 and CA2 fields. On the contrary, the number of branching points of cortical 
neurons from WT and KO mice is comparable. 
We can conclude that the absence of IL1RAPL1 in vivo affects the correct dendrite development in 
the hippocampus. 
 
Identification of IL1RAPL1 protein domains involved in regulating dendritic arborization 
complexity in rat neuronal primary colture  
Hippocampal neurons were transfected at DIV11 with GFP, HA-IL1RAPL1, HA-IL1RAPL2, HA-
IL1RAPL1∆N, HA-IL1RAPL1∆exon6, HA-IL1RAPL1 C31R, HA-IL1RAPL1∆C, HA-
IL1RAPL1∆8, HA-IL1RAPL1 TIR or HA-IL1RAPL1 I643V and were fixed and stained at DIV14-
15 with anti HA and anti MAP2 antibodies to label dendrite morphology (Caceres et al., 1984) (Fig. 
4). Images obtained by confocal microscopy (Fig.4a) were subjected to Sholl analysis and the total 
number of branching points was quantified (Fig. 4b) and plotted on the distance from the soma (Fig. 
4c).  
We found that the overexpression of IL1RAPL1 induce a reduction in number of branching points 
compared to the control (GFP expressing neurons). The overexpression of constructs that present 
mutations and deletions in the intracellular domains of IL1RAPL1 leads to a decreased number of 
branching points like the full length does. On the contrary, the overexpression of mutants in the 
extracellular domains seems not to have an effect on arborization or induce a higher dendrite 
complexity (IL1RAPL1 C31R overexpression) compared to the control.  
We can conclude that the extracellular part of IL1RAPL1 protein seems to be involved in 
controlling dendrite arborization. 
Given that the only know interactor of IL1RAPL1 extracellular domain is PTPδ, we decided to 
understand wether this trans-interaction could be involved on the effect on dendrite arborization.  
In vitro, synaptogenesis process starts later than DIV 4 (Baj et al.), thus we decided to use  
immature neurons to exclude the role of trans-synaptic interaction between IL1RAPL1 and PTPδ in 
the IL1RAPL1 mediated effect on dendrite arborization. 
Hippocampal neurons were transfected at DIV1 with GFP alone or in combination with HA-
IL1RAPL1, HA-IL1RAPL1 C31R, HA-PTPδ, HA-PTPδ ECTO and shRNA against PTPδ and were 
fixed and stained at DIV4 with anti HA and anti MAP2 antibodies (Fig. 5a). Quantification of total 
number of primary (Fig. 5b) and secondary dendrites, (Fig. 5c) and the total length of primary and 
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secondary dendrites (Fig. 5d) of neurons overexpressing IL1RAPL1 and PTPδ constructs was 
performed. 
Also in immature neurons, the overexpression of IL1RAPL1 leads to a semplification of dendritic 
arborization: the total number of primary dendrites is lower respect the control (GFP overexpressing 
neurons) (Fig. 5b). For this effect, the extracellular domain of IL1RAPL1 is required. On the 
opposite, PTPδ ECTO overexpressing neurons present a more complex arborisation (Fig. 5b) and a 
higher length of primary and secondary dendrites (Fig. 5d). The expression of shRNA against PTPδ 
instead reduces the number of secondary dendrites and the total length of primary and secondary 
dendrites. 
From these data we can conclude that the trans-synaptic interaction between IL1RAPL1 and PTPδ 
seems not to be involved in the IL1RAPL1-mediated effect on dendrite arborisation semplification, 
even if PTPδ seems to be involved in early neurite development (Wang and Bixby, 1999; Gonzalez-
Brito and Bixby, 2006). 
 
We then tried to understand wether a possible cis-interaction between IL1RAPL1 and PTPδ 
mediate the IL1RAPL1 effect on dendrite arborisation. We transfected neurons with GFP alone or 
with HA-IL1RAPL1, HA-PTPδ, HA-PTPδ ECTO, HA-PTPδ a-b- and shRNA against PTPδ and 
IL1RAPL1 in combination with HA-PTPδ, HA-PTPδ ECTO and HA-PTPδ a-b- at DIV 11, and we 
then fixed and stained neurons at DIV 14-15 with anti-HA and anti-IL1RAPL1 antibodies. Images 
obtained by confocal microscopy (Fig.6a) were subjected to Sholl analysis and the total number of 
branching points was quantified (Fig. 6b).  
The analysis showed that the co-overexpression of PTPδ full length, PTPδ a-b- and PTPδ ECTO 
block the ability of overexpressed IL1RAPL1 to reduce the total number of branching points. 
Otherwise the shRNA mediated silencing of PTPδ protein leads to the simplification of dendrite 
arborisation like the overexpression of IL1RAPL1 does.  
We can conclude that a cis-interaction between IL1RAPL1 and PTPδ can occur in the dendrite 
compartment and can block the effect of IL1RAPL1 on dendrites. This antagonistic effect of PTPδ 
is confirmed also by the effect of its silencing that rescue the effect of IL1RAPL1 on dendrites. The 
extracellular part of PTPδ seems to be sufficient to block the IL1RAPL1 effect and the absence of 
PTPδ miniexons a and b doesn’t affect the PTPδ capacity of IL1RAPL1 blockade. Possibly, the role 
of the miniexons in the IL1RAPL1-PTPδ interaction (Yoshida et al.) is less important in cis than in 
trans. 
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PTPδ and IL1RAPL1 cis-interaction 
To better characterize the cis-interaction between IL1RAPL1 and PTPδ we decided to look at 
localization of overexpressed PTPδ on dendrite surface membrane in combination or not with 
overexpressed IL1RAPL1. Hippocampal neurons were transfected at DIV11 with GFP, HA-
IL1RAPL1 and IL1RAPL1 in combination with HA-PTPδ and HA-PTPδa-b- (Fig. 7a). At DIV 14-
15, live hippocampal neurons were stained for 10 min at 37°C with anti-HA-tag rabbit antibody to 
label overexpressed protein on the membrane surface. After washing, neurons were fixed and 
incubated with anti-HA-tag mouse antibody in permeabilizing condition. Then primary antibodies 
were labeled with FITC- and Cy3-conjugated secondary antibodies. The ratio of integrated intensity 
of surface HA signal per total HA signal was measured for each neuron, and the mean + SEM is 
shown in the graph (Fig. 7b). 
Like already published (Pavlowsky et al., ; Ramos-Brossier et al.), IL1RAPL1 is clearly present in 
dendrites and on the cell surface, otherwise overexpressed PTPδ at DIV14 is mostly localized in the 
axon (Takahashi and Craig, ; Dunah et al., 2005) and the relative aboundance of protein on the 
dendrite cell surface is lower. The co-overexpression of IL1RAPL1 with PTPδ leads to an increased 
amount of PTPδ on the dendrite cell surface, showing a probable cis-interaction in dendrites 
between the two proteins.   
PTPδ a-b- overexpressing neurons show a more equal distribution between axonal and dendrite 
compartments respect to PTPδ, but the distribution of the protein seems not to change with the co-
overexpression of IL1RAPL1. This experiment suggests that PTPδ is recruited to dendrites by a cis-
interaction with IL1RAPL1. The dendritic recruited PTPδ is probably able to block the effect of 
IL1RAPL1 on dendritic arborisation. 
We can specuate that the cis-interaction is lower or absent between IL1RAPL1 and PTPδ a-b-.  
 
Effect of IL1RAPL1 and PTPδ co-overexpression on synaptogenesis 
The IL1RAPL1 mediated recruitment of presynaptic compartment was already evaluated using 
VGLUT1 and VGAT as markers of excitatory and inhibitory synapses (Pavlowsky et al., ; Ramos-
Brossier et al., ; Valnegri et al.).  
Knocking-down or overexpressing IL1RAPL1 decreases or increases excitatory synapse formation, 
respectively (Pavlowsky et al., ; Valnegri et al., ; Yoshida et al., ; Yoshida and Mishina, 2008). In 
order to evaluate the inhibitory effect of PTPδ mediated by the cis-interaction with IL1RAPL1 in 
dendrites, hippocampal neurons were transfected at DIV11 with GFP, HA-IL1RAPL1 and 
IL1RAPL1 alone or in combination with HA-PTPδ than fixed a DIV 14-15 and stained with anti-
HA, anti-VGLUT1 and anti-VGAT antibodies (Fig. 8a and 9a). Quantification of VGLUT1 and 
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VGAT clusters intensity in neurons overexpressing IL1RAPL1 and PTPδ was evaluated (Fig. 8b 
and 9b). 
Our results show, as expected that the overexpression of PTPδ full length doesn’t affect the 
excitatory and inhibitory synapses recruitment. However, the co-overexpressed PTPδ blocks the 
IL1RAPL1 mediated recruitment of excitatory presynaptic compartment. 
Thus our data indicate that the cis-interaction between IL1RAPL1 and PTPδ occurs at the 
extracellular domain and block the effect of IL1RAPL1 on dendrites and on pre-synaptic 
compartment. 
 
IL1RAPL1-KO mice behavioral tests 
3 months old IL1RAPL1-KO and WT mice undergo some behavioural test to asses if the knocking 
down of the protein can reflect some of the phenotypes typical of ID and ASD patients and thus if 
IL1RAPL1-KO mouse can be consider as a good model to study this pathologies. 
Results from behavioural studies indicate that KO mice were healthy showing normal sensory 
abilites (olfactory test, Fig. 10), normal innate behaviour (nest building test, data not shown) and 
normal sociability features (data not shown). 
In the olfactory test, the latency to find the buried palatable food is recorded and no differences 
were observed between WT and KO mice. 
Mice were subjected to Passive Avoidance test. The time latency to learn the association between 
the shock and the dark compartment was measured (Fig. 11) and no difference was found between 
WT and IL1RAPL1-KO mice. This finding suggests that KO mice show a good performance in a 
test that measure cortical and hippocampal area activity. 
The spontaneous motor activity of WT and KO mice was also evaluated (Fig. 12). KO animals are 
characterized by an increased number of horizontal and vertical beam breaks, thus presenting a 
clear hyperactivity feature respect WT mice.  
The Morris water maze test was chosen to asses the mice capacity to remember the position of an 
hidden platform submerged below the water surface (Fig. 13). IL1RAPL1-KO mice need more time 
to find the platform respect WT mice, showing a decreased spatial memory capacity that suggests 
an altered hippocampal activity. 
The Elevated Plus Maze paradigm was used to study anxiety related behavior (Fig. 14). The number 
of open- and closed-arm entries and the time spent in open and closed arms were recorded for 5
min. KO mice show a slight less anxiety compared to WT as shown by the increased time to remain 
in the open arm. 
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Western Blot analysis on WT, HET and IL1RAPL1 KO mice 
To identify possibly major synaptic biochemical alteration in the IL1RAPL1 KO mice total brain, 
lysate and crude synaptosomal fraction from 3 months old female WT, HET and IL1RAPL1 KO 
mice were analysed by Western Blot using a panel of antibodies against pre- and post-synaptic 
proteins (Fig. 15). We didn’t find any major difference in synaptic protein expression between the 
genotypes.   
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Fig. 1. Dendritic arborization complexity of CA1 hippocampal neurons is altered in IL1RAPL1-KO adult mice 
 (A) Representative images of Golgi stained brain from WT (on the left) and IL1RAPL1 KO mice (on the right) and a 
schematization of their dendrites below. 
(B) Quantification of total number of neuronal branching points from WT and IL1RAPL1-KO mice (8 neurons 
analyzed for each mice, N=9 for each genotype). Data are shown as mean of number of branching points ± SEM, 
*p<0.05, **p < 0.005, student’s t-test. 
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(C) Quantification of the number of branching points from WT and IL1RAPL1-KO mice plotted on the distance from 
the soma (µm). All values represent mean of total branching points every 10 µm ± SEM, *p<0.05, **p<0.005, 
***p<0.001, student’s t-test. 
 
Fig. 2. Dendritic arborization complexity of CA2 hippocampal neurons is altered in IL1RAPL1-KO adult mice. 
(A) Representative images of Golgi stained brain from WT (on the left) and IL1RAPL1 KO mice (on the right) and a 
schematization of their dendrites below. 
(B) Quantification of total number of neuronal branching points from WT and IL1RAPL1-KO mice (8 neurons 
analyzed for each mice, N=4 for each genotype). Data are shown as mean of number of branching points ± SEM, 
*p<0.05, student’s t-test. 
RESULTS 
 
56 
(C) Quantification of the number of branching points from WT and IL1RAPL1-KO mice plotted on the distance from 
the soma (µm). All values represent mean of total branching points every 10 µm ± SEM. 
Fig. 3. WT and IL1RAPL1-KO adult mice dendritic arborization complexity in Occipital and Parietal cortex. 
(A) Representative images of Golgi stained brain from WT (on the left) and IL1RAPL1 KO mice (on the right) and a 
schematization of their dendrites below. 
(B) Quantification of total number of neuronal branching points from WT and IL1RAPL1-KO mice (8 neurons 
analyzed for each mice, N=7 for each genotype). Data are shown as mean of number of branching points ± SEM. 
(C) Quantification of the number of branching points from WT and IL1RAPL1-KO mice plotted on the distance from 
the soma (µm). All values represent mean of total branching points every 10 µm ± SEM. 
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Fig. 4. Dendritic arborization complexity quantification in neuronal primary colture.  
(A) Hippocampal neurons were transfected at DIV11 with GFP, HA-IL1RAPL1, HA-IL1RAPL2, HA-IL1RAPL1∆N, 
HA-IL1RAPL1∆exon6, HA-IL1RAPL1 C31R, HA-IL1RAPL1∆C, HA-IL1RAPL1∆8, HA-IL1RAPL1TIR or HA-
IL1RAPL1 I643V and were fixed and stained at DIV14 with anti HA and anti MAP2 antibodies. Each row of images 
(except for GFP one) shows double labeling for MAP2 (red, middle panel) and HA (green, right panel); merge is shown 
in color, in left panel. 
(B) Quantification of total number of branching points of neurons overexpressing IL1RAPL1 constructs (15 neurons 
analyzed for each construct in three independent experiments). All values represent mean ± SEM, *p<0.05, **p<0.005, 
***p < 0.001, ANOVA followed by Dunnet’s post-hoc test. 
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(C) Quantification of number of branching points of neurons overexpressing IL1RAPL1 constructs plotted on the 
distance from the soma (µm). All values represent mean of total branching points every 50 µm ± SEM, *p<0.05, 
**p<0.005, ***p < 0.001, ANOVA followed by Dunnet’s post-hoc test. 
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Fig. 5. Dendritic arborization complexity quantification in immature neurons.  
(A) Hippocampal neurons were transfected at DIV1 with GFP, HA-IL1RAPL1, HA-IL1RAPL1 C31R, HA-PTPδ, HA-
PTPδ ECTO and shRNA against PTPδ and were fixed and stained at DIV4 with anti HA and anti MAP2 antibodies. 
Each row of images (except for GFP one) shows GFP signal and labeling for MAP2 (blue) and HA (red); merge is 
shown in color, in right panel. 
Quantification of total number of primary dendrites, (B) secondary dendrites, (C) total length of primary and secondary 
dendrites of neurons (D) overexpressing IL1RAPL1 and PTPδ constructs (15 neurons analyzed for each construct in 
three independent experiments). All values represent mean ± SEM, *p<0.05, **p<0.005, compared to control °p<0,005 
respect to IL1RAPL1 full lenght (ANOVA followed by Tukey’s post-hoc test). 
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Fig. 6. Dendritic arborization complexity quantification in neuronal primary colture.  
(A) Hippocampal neurons were transfected at DIV11 with GFP, IL1RAPL1, PTPδ constructs and shRNA against PTPδ 
and were fixed and stained at DIV15 with anti HA (red) and anti-IL1RAPL1 (green).  
(B) Quantification of total number of branching points of neurons overexpressing IL1RAPL1 and PTPδ constructs (15 
neurons analyzed for each construct in three independent experiments). All values represent mean ± SEM, *p<0.05, ** 
p <0.005, ***p < 0.001 (ANOVA followed by Tukey’s post-hoc test). 
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Fig. 7. PTPδ and IL1RAPL1 cis-interaction. 
(A) Total (left panel) and surface (middle panel) staining of HA-PTPδ and HA-PTPδa-b- in mature hippocampal 
neurons using an anti-HA tag antibody. The ratio of integrated intensity of surface HA signal per total HA signal was 
measured for each neuron, and the mean + SEM is shown in (B). All values represent mean ± SEM, **p<0.005, 
compared to control °°p<0,005 respect to PTPδ (ANOVA followed by Tukey’s post-hoc test). 
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Fig. 8. Effect of IL1RAPL1 and PTPδ co-overexpression on excitatory synapse formation. 
(A) Rat hippocampal neurons transfected with GFP, IL1RAPL1, HA-PTPδ and stained with anti-VGLUT1 antibody to 
label excitatory pre-synapses. Images show labeling for GFP (green), IL1RAPL1 (green), HA (green) and VGLUT1 
(red); the merged images are shown in the right panel.  
(B) Quantification of VGLUT1 clusters intensity. Bar graphs show the mean + SEM of VGLUT1 intensity (15 neurons 
from 3 independent experiments for each condition, ** p <0.005, compared to control neurons).  
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Fig. 9. Effect of IL1RAPL1 and PTPδ co-overexpression on inhibitory synapse formation. 
(A) Rat hippocampal neurons transfected with GFP, IL1RAPL1, HA-PTPδ and stained with anti-VGAT antibody to 
label excitatory pre-synapses. Images show labeling for GFP (green), IL1RAPL1 (green), HA (green) and VGAT (red); 
the merged images are shown in the right panel.  
(B) Quantification of VGAT clusters intensity. Bar graphs show the mean + SEM of VGAT intensity (15 neurons from 
3 independent experiments for each condition).  
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Fig. 10. Mice behavior: Olfactory test (Data obtained in collaboration with Luisa Ponzoni from Maria Elvina Sala 
Laboratory).  Latency to find an hidden palatable food is recorded and plotted in seconds ± SEM.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11. Mice behavior: Passive avoidance test (Data obtained in collaboration with Luisa Ponzoni from Maria Elvina 
Sala Laboratory).  The test apparatus consisted of one light and one dark compartments, connected via a sliding door. In 
the acquisition trial, each mouse was placed in the light compartment and allowed to enter the dark compartment; the 
time (in s) taken to do so was recorded. Once the mouse was in the dark compartment, the sliding door was closed and 
an unavoid- able electric shock delivered via the paws. The animal was then placed back in the home cage until the 
retention trial. The retention trial was carried out 30 min or 24 h after the acquisition trial, by positioning the mouse in  
the light compartment and recording the time taken to enter the dark compartment. ∆sec are plotted ± SEM.   
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Fig. 12. Mice behavior: spontaneous motor activity (Data obtained in collaboration with Luisa Ponzoni from Maria 
Elvina Sala Laboratory). The spontaneous motor activity of WT and KO mice was evaluated: cumulative horizontal and 
vertical beam breaks were counted for 60 min. In the upper raw of graph the total number of horizontal and vertical 
mouvements are plotted together or divided in 30 minutes time intervals. In the bottom raw of graph, the counts are 
plotted on the minuts.  
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Fig. 13. Mice behavior: Morris water maze (Data obtained in collaboration with Luisa Ponzoni from Maria Elvina Sala 
Laboratory). The escape latency and time spent in the target zone of the maze were manually recorded.  
 
 
 
 
Fig. 14. Mice behavior: Elevated Plus Maze (Data obtained in collaboration with Luisa Ponzoni from Maria Elvina Sala 
Laboratory). The Elevated Plus Maze paradigm was used to study anxiety related behavior. The number of open- and 
closed-arm entries and the time spent in open and closed arms were recorded for 5 min. 
 
RESULTS 
 
67 
 
 
 
 
 
 
Fig. 15. Western Blot analysis on total brain lysate and crude synaptosomal fraction from WT, HET and IL1RAPL1 KO 
mice.  
(A) Western Blot analysis of 3 months old female WT, HET and IL1RAPL1 KO mice.   
(B) Quantification of the integrated density of the bands, normalized on Actin ± SEM (ANOVA followed by Tukey’s 
post-hoc test, * p <0.05, ** p <0.005, ***p < 0.001 compared to WT mice).  
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NOVEL IL1RAPL1 MUTATIONS ASSOCIATED WITH INTELLECTUAL DISABILITY 
IMPAIR SYNAPTOGENESIS 
Discussion of the results about the function of the three novel independent mutations of IL1RAPL1 
gene IL1RAPL1∆exon6, IL1RAPL1 C31R and IL1RAPL1 I643V has already been published 
(Ramos-Brossier et al.), thus it is not reported in this Thesis. 
 
 
THE X-LINKED INTELLECTUAL DISABILITY PROTEIN IL1RAPL1 REGULATES 
DENDRITIC ARBORIZATION  
Dendrites must satisfy many physiological requirements to ensure proper neuronal function. 
Numerous molecules and pathways are involved in the correct dendrite development, maintainment 
and function. For instance, actin and microtubules are the major structural components that underlie 
dendrite morphology and regulators of actin and microtubule dynamics therefore have important 
roles in dendrite morphogenesis (Leemhuis et al., 2004; Newey et al., 2005; Chen and Firestein, 
2007; Sfakianos et al., 2007). Furthermore, in vivo studies indicate that synaptic activity promotes 
dendritic arbor elaboration and stabilization (Cline, 2001). In some cases, blocking synaptic activity 
induces an increase of dendritic growth. For example, blocking glutamate receptors or L-type 
calcium channels increases dendritic growth of pyramidal and nonpyramidal neurons in cultured 
slices of ferret visual cortex (McAllister, 2000). Blocking NMDA receptors in neonatal ferrets in 
vivo also increases dendritic branching and spine formation in neurons in the lateral geniculate 
nucleus (Rocha and Sur, 1995). Thus, the effects of neuronal activity and molecular mechanisms on 
dendritic morphology may be site- and context-dependent and may differ between animal species 
and between brain regions (McAllister, 2000).  
Consistent with the necessity of appropriate dendritic architecture for high order brain functions, 
(including learning and memory), deficiencies in the architecture of dendrites have been observed in 
a variety of neurodevelopmental, neurodegenerative and neuropsychiatric disorders such as 
schizophrenia, Down’s syndrome, fragile X syndrome, Angelman’s syndrome, Rett’s syndrome and 
autism (Verpelli et al., ; Miller and Kaplan, 2003; Bagni and Greenough, 2005; Pardo and Eberhart, 
2007; Ramocki and Zoghbi, 2008; Walsh et al., 2008; Bourgeron, 2009). 
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Decreased dendritic branching in CA1 and CA4 hippocampal neurons occurs in patients with 
autism and neurons from patients with Rett syndrome. Similarly, altered dendritic arborization and 
decreased expression of glutamate receptors have been observed in CA3 hippocampal neurons of 
patients with schizophrenia (Kolomeets et al., 2007). Thus, an abnormality in the dendritic arbor is 
a common theme seen in disorders of the central nervous system and these aberrations may be 
directly linked to deficiencies in higher order brain functions (Arikkath). 
Mutations in IL1RAPL1 gene have been found in patients with ID or autism (Carrie, 1999; Piton, 
2008). Thus we decided to study the neuronal morphology in IL1RAPL1 KO mice and rat neuron 
primary culture overexpressing IL1RAPL1 or IL1RAPL1 mutants to clarify how any changes in 
IL1RAPL1 function can lead to development of cognitive disorders in humans. 
Piton et al. have characterized the functional impact of the I367SfsX6 mutation on IL1RAPL1 
activity. The authors first carry on some expression studies of mouse IL1RAPL1 gene and found the 
highest level of expression of IL1RAPL1 in the developing and post-natal hippocampus (Carrie et 
al., 1999), a structure involved in memory that have been shown to be altered in ASD patients 
(Cody et al., 2002). In cultures of rat hippocampal neurons IL1RAPL1 endogenous protein is 
present in the cell body but also in growth cones of short, dendrite-like processes. To determine the 
effect of the I367SfsX6 mutation on ILRAPL1 function in HEK293 cells, Piton et al. knocked down 
the expression of the endogenous ILRAPL1 using specific miRNAs. The knock-down of 
IL1RAPL1 leads to a significant increase in both the number and the length of neuritis. 
Cotransfection of the anti-endogenous IL1RAPL1 miRNA together with the full-length wild-type 
IL1RAPL1 cDNA restored the expression of IL1RAPL1 and rescued the neurite outgrowth activity 
to control levels. In contrast, cotransfection of the miRNA together with the IL1RAPL1 I367SfsX6 
mutant cDNA resulted in cells with high neurite number and length, similar to cells transfected with 
the miRNA alone. Therefore, the mutated IL1RAPL1 protein was unable to rescue ILRAPL1 
knockdown. This observation shows that the 7 bp deletion results in a loss of IL1RAPL1 function. 
Moreover, immunofluorescence studies using an antibody directed against IL1RAPL1 protein 
revealed a cytoplasmic pool of mutant protein but did not detect its presence at the cell surface, 
suggesting that the truncated form of IL1RAPL1 is mislocalized. Surprisingly, transfection of rat 
hippocampal neurons with either the human WT or the mutant IL1RAPL1 cDNA alone did not 
affect neurite outgrowth.  In conclusion, Piton et al. demonstrated a role of IL1RAPL1 in neurite 
outgrowth. 
Furthermore, Gambino et al. (Gambino et al., 2007) reported that the expression of IL1RAPL1 in 
PC12 cells, a neuron-like cell line in which it is not normally expressed, decreases neurite 
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outgrowth by inhibiting N-type voltage-gated calcium channels via its physical interaction with 
NCS-1/FREQ.  
 
Given the emerging role of IL1RAPL1 in neurite outgrowth we decided to investigate this effect in 
vivo and in vitro. 
We performed an analysis of dendritic arborisation complexity on Golgi stained neurons of CA1 
(Fig. 1), CA2 (Fig. 2) and Occipital and Parietal cortex (Fig. 3) in WT and IL1RAPL1 KO mice. 
We observed an increased number of branching points in IL1RAPL1-KO mice hippocampal 
neurons of CA1 and CA2 fields. On the contrary, the number of branching points of cortical 
neurons from WT and KO mice is comparable. These results suggest that the absence of IL1RAPL1 
in vivo affects the correct dendrite development in the hippocampus, but not in the cortex. 
We can speculate that the effects of the protein on dendritic morphology may be site-dependent, 
thus IL1RAPL1 and its hypothetical interactors can have different role in different brain areas.    
Thus, it will be also interesting to study if the expression of synaptic and neuronal proteins is 
modified by the KO of IL1RAPL1 in different brain area. Up to now, we didn’t find any major 
differences in synaptic protein expression between KO, HET and WT animals (Fig. 15).  
   
To understand wich IL1RAPL1 protein domains are involved in the effect on dendrite branching, 
we performed some in vitro experiments. 
The overexpression of IL1RAPL1 drives to a reduction in number of branching points compared to 
the control (GFP expressing neurons). The overexpression of constructs that present mutations and 
deletions in the intracellular domains of IL1RAPL1 leads to a decreased number of branching 
points like the full length does. On the contrary, the overexpression of mutants in the extracellular 
domains seem not to have an effect on arborization or to lead to a higher dendrite complexity 
(IL1RAPL1 C31R overexpression) compared to the control.  
Our data indicate that the extracellular part of IL1RAPL1 protein seems to be involved in this effect 
on dendrite arborization. 
Given that the only known interactor of IL1RAPL1 extracellular domain is PTPδ and that the entire 
extracellular domain of PTPδ can function as a ligand to promote cell adhesion and neurite 
outgrowth (Gonzalez-Brito and Bixby, 2006), we decided to understand wether their trans-
interaction could be involved in the effect on dendrite arborization.  
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In vitro, synaptogenesis process starts later than DIV 4 (Baj et al.), thus we decided to use young 
neurons to exclude the role of trans-synaptic interaction between IL1RAPL1 and PTPδ in the 
IL1RAPL1 mediated effect on dendrite arborization. 
In young and synaptic immature neurons like in old ones, the overexpression of IL1RAPL1 leads to 
a semplification of dendritc arborization: the total number of primary dendrites is lower respect the 
control (GFP overexpressing neurons) (Fig. 5b). Moreover, PTPδ ECTO overexpressing neurons 
present a more complex arborisation (Fig. 5b) and a higher length of primary and secondary 
dendrites (Fig. 5b and 5d). The expression of shRNA against PTPδ seems to affect the number of 
secondary dendrites and the total length of primary and secondary dendrites. 
From these data we can conclude that the trans-synaptic interaction between IL1RAPL1 and PTPδ 
seems not to be involved in the IL1RAPL1-mediated effect on dendrite arborisation simplification, 
even if PTPδ is involved in neurite development. 
Given that the trans-synaptic interaction seems not to be involved, we tried to understand wether a 
possible cis-interaction between IL1RAPL1 and PTPδ could explain the IL1RAPL1-mediated effect 
on dendrite arborisation. For this porpoise, we transfected neurons with IL1RAPL1 plus PTPδ 
constructs in mature neurons (transfection at DIV 11 and staining at DIV 14-15). Surprisingly, we 
found that the co-overexpression of PTPδ constructs block the effect of overexpressed IL1RAPL1 
on dendrite development. On the other hand, the shRNA mediated silencing of PTPδ protein leads 
to the simplification of dendrite arborisation like the overexpression of IL1RAPL1 does. 
These data suggest that a cis-interaction between IL1RAPL1 and PTPδ can occur and can block the 
effect of IL1RAPL1 on dendrites. This antagonistic effect of PTPδ also suggested by the effect of 
PTPδ silencing mimics the effect of IL1RAPL1 overexpression. Possibly, the absence of 
endogenous PTPδ releases the activity on dendrites of endogenous IL1RAPL1. The extracellular 
part of PTPδ seems to be sufficient to block the IL1RAPL1 effect on dendrites because PTPδ 
ECTO is enough to block IL1RAPL1 activity. However we cannot completely explain why PTPδ 
without miniexons a and b, that should not binds to IL1RAPL1, is also able to block I1RAPL1 
activity. It is possible that the role of the miniexons in the IL1RAPL1-PTPδ interaction (Yoshida et 
al.) is less important in cis than in trans. 
Two experiments further demonstrate the abilty of PTPδ to interfere with IL1RAPL1 activity on 
dendrites. 
First we studied the distribution of overexpressed PTPδ in dendrites plus or minus IL1RAPL1. We 
found that, like already published (Pavlowsky et al., ; Ramos-Brossier et al.), IL1RAPL1 is clearly 
present in dendrites and on the cell surface, otherwise PTPδ overexpressing neurons show a mostly 
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axonal staining (Takahashi and Craig, ; Dunah et al., 2005) and the relative aboundance of protein 
on dendrite membrane surface is low. Instead the co-overexpression of PTPδ with IL1RAPL1 leads 
to an increased amount of PTPδ on dendrite membrane surface, showing the recruitment of PTPδ to 
dendrites mediate by a probable cis-interaction between the two proteins.   
We also found that overexpressed PTPδ a-b-, unable to bind IL1RAPL1 (Yoshida et al.) is more 
diffuse and is also localized in dendrites staining respect to PTPδ, but the distribution of the protein 
seems not to change with the co-overexpression of IL1RAPL1. 
Our data suggest that the cis-interaction is lower between IL1RAPL1 and PTPδ a-b-, however PTPδ 
a-b- is someway still able to block the effect of IL1RAPL1 on dendrites morphology. 
We also analyzed the effect of IL1RAPL1 and PTPδ co-overexpression on synaptogenesis. The 
IL1RAPL1 mediated recruitment of presynaptic compartment was already evaluated using 
VGLUT1 and VGAT as markers of excitatory and inhibitory synapses (Pavlowsky et al., ; Ramos-
Brossier et al., ; Valnegri et al.).  
Knocking-down or overexpressing IL1RAPL1 decreases or increases excitatory synapse formation, 
respectively (Pavlowsky et al., ; Valnegri et al., ; Yoshida et al., ; Yoshida and Mishina, 2008).  
Interestingly we found that the co-overexpression of IL1RAPL1 and PTPδ block the IL1RAPL1 
mediated recruitment of excitatory presynaptic compartment. 
 
Thus, our in vitro results suggest that IL1RAPL1 extracellalar domains play a role in dendrite 
morphology and that the cis-interaction with PTPδ is able to block the IL1RAPL1-induced 
semplification of dendrite branching. 
Our hypothesis is that an unknown IL1RAPL1 interactor is involved in the effect on dendrite 
morphology, in particular, because only in hippocampus neurons of IL1RAPL1 KO mice the 
dendrite morphology is altered, we plan to search for an IL1RAPL1 interactor with a primary role 
in hippocampal functions development or manteinment. 
 
Our results from behavioural studies on WT and IL1RAPL1 KO mice indicate that the absence of 
the protein doesn’t affect the sensory abilites and the innate behaviour of the animals.  
Interestingly, findings emerging from memory function tests suggest that KO mice are able of good 
performance in depending on cortical and hippocampal area tasks (Passive Avoidance test), but 
present an impairment in Spatial memory test (Morris water maze).  
We can conclude that KO animals are charachterized by an essentially hippocampal altered activity.  
Furthermore, IL1RAPL1-KO mice present a clear hyperactivity feature and a slight less anxiety 
compared to WT mice.  
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The learning deficiencies and memory declines observed in IL1RAPL1-KO mice (Houbaert et al., ; 
Pavlowsky et al., ; Yasumura et al., ; Gambino et al., 2009) mimic the symptoms of ID children 
with IL1RAPL1 mutations. ID children with deletions in the IL1RAPL1 gene have slow 
developmental milestones such as the onsets of walking and speech and require special education 
(Barone et al., ; Behnecke et al., ; Franek et al., ; Nawara et al., 2008). 
The IL1RAPL1 gene is also associated with ASDs (Youngs et al., ; Bhat et al., 2008; Piton et al., 
2008). ASDs are characterized by impairments in appropriate reciprocal social interactions, 
impairments in verbal social communication and high levels of ritualistic repetitive behaviours 
(Crawley, 2004). 
Interestingly, IL1RAPL1 knockout mice in the spontaneous motor activity test showed an enhanced 
locomotor activity, which may be interpreted that IL1RAPL1 knockout mice are more prone to be 
stereotypic in behavior and that hyperactive behaviour (Yasumura et al.) reported for ID patients 
with mutations in the IL1RAPL1 gene (Barone et al., ; Behnecke et al., ; Franek et al., ; Nawara et 
al., 2008) was reproduced in IL1RAPL1 knockout mice. 
However, the social interaction of IL1RAPL1 knockout mice was not different from WT animals 
(data not shown).   
We also noted that anxiety was reduced in IL1RAPL1 knockout mice. To measure anxiety-like 
behaviour in mice, elevated plus maze test is widely used (Bishop and Lahvis, ; Crawley). The 
percentages of time on open arms and entry into open arms in IL1RAPL1 knockout mice were 
significantly higher than those of wild-type mice. Thus, anxiety-like behaviours of IL1RAPL1 
knockout mice are consistently reduced. 
Present study with mutant mice (Houbaert et al., ; Pavlowsky et al., ; Yasumura et al., ; Gambino et 
al., 2009) revealed that the ablation of IL1RAPL1 affects diverse brain functions including learning, 
memory, and anxiety. Thus, it is reasonable that multiple brain functions are affected by the 
Mutation (Yasumura et al.).  
Human patients with IL1RAPL1 mutations are classified as ID and/or ASDs (Barone et al., ; 
Behnecke et al., ; Franek et al., ; Youngs et al., ; Carrie et al., 1999; Tabolacci et al., 2006; Bhat et 
al., 2008; Nawara et al., 2008; Piton et al., 2008). It remains to be examined how neural
circuits responsible for these mental disorders are mainly affected by IL1RAPL1 mutations. 
Interestingly, model mice of Fragile X syndrome, the most common ID, show decreased anxiety, 
increased locomotor activity and mild or no deficits in spatial learning (Peier et al., 2000; Mineur et 
al., 2002; Eadie et al., 2009). Based on the fact that FMRP regulates activity-dependent local 
mRNA translation upon metabotropic glutamate receptor 5 (mGluR5) stimulation, trials for the 
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treatment of Fragile X syndrome using mGluR5 antagonists have begun (Yasumura et al.). An 
increasing number of trials focus on treatment of the underlying defect, via re-equilibration of the 
biochemical imbalance that results from genetic mutations (Picker and Walsh). IL1RAPL1 induces 
excitatory synapse formation by trans-synaptic interaction with PTPδ (Valnegri et al., ; Yoshida et 
al.) and controls AMPA receptor trafficking by interacting with Mcf2l (Hayashi et al.). The 
decrease of spine density will cause the imbalance of excitation and inhibition in multiple brain 
circuits.  
Our study reported for the fist time that IL1RAPL1 also regulate dendrite morphogenesis 
specifically in the hippocampus. Thus we propose that same hippocampal deficits identified in mice 
and presumably also in human patients carring IL1RAPL1 mutation are caused by altered dendrite 
arborization of hippocampal neurons. 
Further investigation of the molecular mechanism of IL1RAPL1-mediated effect on synaptogenesis 
and dendrite morphology would identify potential drug targets and IL1RAPL1 knockout mice will 
be useful to assess the new possible treatments (Yasumura et al.). 
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